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Abstract 
Inemo Ebinyo Asamaowei 
The Role of Polycomb Repressive Complex 2 in Epidermal Homeostasis and 
Hair Growth 
Keywords: Skin, epidermis, hair follicle, Polycomb group proteins, EZH2, 
differentiation 
Polycomb repressive complex 2 (PRC2) catalyses the methylation of ‘Lys-27’ 
of histone H3, leading to transcriptional repression of target genes through its 
catalytic subunit Enhancer of zeste homolog 1/2 (EZH1/2). PRC2 functions 
as a critical regulator of stem cells in mouse embryonic and adult tissues. 
However, the role of PRC2 in human skin remains largely unknown.  
This study investigated the role of PRC2 in human epidermal homeostasis 
and hair growth. The expression of EZH2 was elevated in differentiating 
suprabasal layers of the human epidermis. Consistently, EZH1/2 expression 
and enzymatic activity was upregulated in differentiating primary human 
keratinocytes (NHEKs) in vitro. Inhibition of EZH2 and Embryonic ectoderm 
development (EED) in NHEKs stimulated the expression of differentiation-
associated genes, therefore leading to their premature differentiation; while 
inhibition of EZH1/2 reduced cell proliferation and promoted apoptosis. 
Silencing of EZH2 in NHEKs induced complex changes in gene expression 
programmes, including the upregulation of terminal differentiation genes, 
such as Filaggrin. EZH2 expression was downregulated in aged 
keratinocytes accompanied with upregulation of senescence-associated 
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genes, p16INK4A and p19INK4D, suggesting EZH2 involvement in epidermal 
aging.  
In human anagen hair follicle (HF), EZH2 was detected in stem and 
progenitor cells; and hair matrix keratinocytes. Silencing EZH2 in HFs 
accelerated anagen-catagen transition and retarded hair growth 
accompanied by decreased proliferation and increased apoptosis. Silencing 
EZH2 in outer root sheath keratinocytes resulted in upregulation of 
p14ARFand K15, suggesting EZH2 involvement in regulating proliferation and 
stem cell activity.      
Thus, this study demonstrates that PRC2-mediated repression is crucial for 
epidermal homeostasis and hair growth. Modulating the activities of PRC2 in 
skin might offer a new therapeutic approach for disorders of epidermal 
differentiation and hair growth. 
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CHAPTER 1: INTRODUCTION 
 
 
1.1 Functions of the skin 
Mammalian skin covers a surface area of about 2m2 accounting for about 
16% of total body weight and is essential for the survival of an organism 
(Tobin, 2006; Wickett and Visscher, 2006). It acts as coverage and a barrier 
protecting the internal organs of the body from the external environment. It 
also acts as a protective barrier against fluid loss, toxic chemical exposure, 
infectious agents, mechanical damage and ultraviolet radiation (Costin and 
Hearing, 2007; Tobin, 2006). It plays important roles in thermoregulation by 
secreting sweat and constricting blood vessels thereby increasing or 
reducing heat loss (Fuchs, 2007; Koster and Roop, 2007). Sensory receptors 
in the skin enable an organism to detect touch, temperature, pain, pressure 
and vibration. Skin can synthesize vitamin D3 from cholesterol upon direct 
contact with sunlight. This enables the skin to perform an endocrine function 
(Lips, 2006). The skin also plays an important role in terms of appearance 
and social interactions. In addition to all the above functions, the skin is also 
a self-renewing organ that can heal itself upon injury (Segre, 2006). An array 
of cell types in the skin enables it to perform these diverse functions. The cell 
types in the skin include keratin producing keratinocytes, collagen 
synthesizing fibroblasts, melanin producing melanocytes, energy storing 
adipocytes, somatosensory Merkel cells and immune cells such as 
Langerhans cells (Costin and Hearing, 2007; Heath and Carbone, 2013; 
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Tobin, 2006). In addition, the skin is enriched with various stem cells 
populations that include α6+/β1+/CD71- epidermal stem cells, 
CD200+/K15+/K19+ hair follicle stem cells (HFSCs) in the bulge and c-kit+ hair 
follicle melanocyte stem cells (Botchkareva et al., 2001; Inoue et al., 2009; Li 
et al., 1998; Nishimura et al., 2002). 
Skin appendages include eccrine and apocrine sweat glands, hair, hair 
follicles, sebaceous glands and nails (Tobin, 2006).  
 
1.2. Structure of the skin 
The skin in mammals is a multi-layered organ that consists of three main 
layers namely:  
 The epidermis, largely made up of specialized epithelial cells known 
as keratinocytes; other cells types include melanocytes, Langerhans 
cells and Merkel cells;  
 The dermis, largely made up of mesenchymal cells such as 
fibroblasts; other cell types include mast cells, telocytes and 
macrophages;   
 The hypodermis or subcutis, largely made up of adipose tissues 
(adipocytes) (Fuchs, 2007; McGrath and Uitto, 2016; Tobin, 2006).  
The epidermis is stratified into four layers and the dermis consists of two 
layers (Figure 1.1). 
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Figure 1.1 – The human skin. A diagram of human skin showing the four 
layers of the epidermis, the dermis, fat of subcutis (Hypodermis) and skin 
appendages (McGrath and Uitto, 2016) 
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1.2.1. Epidermis 
 
During embryonic development, a single layer of epidermal progenitor 
keratinocytes give rise to the epidermis, hair follicle and sebaceous gland 
through various regulatory pathways such as Notch and Wnt signalling 
pathways (Yi and Fuchs, 2010). Mammalian epidermis is a stratified 
squamous epithelium (Figure 1.1) that retains the ability to self-renew under 
homeostatic and injury conditions by maintaining a population of mitotically 
active cells in the hair follicle and innermost basal layer (Segre, 2006). Under 
homeostatic conditions, these mitotically active cells exit the innermost basal 
layer, stop proliferating and undergo terminal differentiation as they move 
through the 3 upper layers of the epidermis eventually forming the cornified 
envelope (Watt et al., 1988).  
Many genes encoding major proteins involved in terminal differentiation, 
such as Filaggrin and Loricrin, are located within a 2Mb region on human 
chromosome 1q21, known as epidermal differentiation complex (EDC). 
These EDC proteins are derived from at least three families of structurally, 
functionally and evolutionary related genes (Marenholz et al., 2001; Mischke 
et al., 1996; Volz et al., 1993; Zhao and Elder, 1997).  
Terminal differentiation programme in the epidermis is regulated by a 
number of transcription factor families and long non-coding RNAs such as 
AP1, AP2, KLFs, p63, ANCR and TINCR (Eckert et al., 2013; Jaubert et al., 
2003; Kouwenhoven et al., 2015; Kretz et al., 2013; Kretz et al., 2012; 
Truong et al., 2006).   
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1.2.1.1. Stratum Basale (Basal layer) 
The stratum basale is the innermost layer of the epidermis that is adjacent to 
the dermis (Figure 1.1). It consists of a monolayer of mitotically active 
keratinocytes that express keratin 5 (K5), keratin 14 (K14) and keratin 15 
(K15) (Alam et al., 2011; Bose et al., 2013). Basal keratinocytes are attached 
to the basement membrane by hemidesmosomes (Tsuruta et al., 2011). K5 
and K14 form keratin filaments that maintains the structural integrity of the 
skin (Bowden et al., 1987). 
A small population of slow cycling epidermal stem cells are found in the 
basal layer and are proposed to give rise to transient amplifying cells, which 
terminally differentiate to generate the differentiated progeny (Watt, 1998).   
Melanocytes which are pigment producing cells are also found in the basal 
layer. Melanocytes produce melanin pigment which is transferred into 
surrounding keratinocytes via melanosomes. Melanin is responsible for skin 
colouration and protects epidermal cells from harmful effects of UV radiation 
(Costin and Hearing, 2007; Singh et al., 2010; Tarafder et al., 2014). 
Also found in the basal layer are Merkel cells, which are neuroendocrine 
cells involved in mechanoreception (Boulais and Misery, 2007).  
As keratinocytes withdraw from the cell cycle and commit to terminal 
differentiation, they remain transcriptionally active and move towards the 
surface of the skin from the stratum basale to the stratum spinosum. 
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1.2.1.2. Stratum Spinosum (Spinous layer) 
The stratum spinosum lies immediately above the stratum basale and 
consists of several layers of cells (Figure 1.1). As keratinocytes enter the 
spinous layer, they switch from expressing K5 and K14 to keratin 1(K1) and 
keratin 10 (K10). K1 and K10 form dense keratin filaments that provide inner 
strength to these cells (Bowden et al., 1987). In addition to the keratins, 
keratinocytes in this layer start producing involucrin and transglutaminase 
(Rice and Green, 1979). Desmosomes connect the cells to one another (Moll 
et al., 2008).  
In addition to keratinocytes, Langerhans cells, which are antigen-presenting 
dendritic cells involved in the skin’s adaptive immune responses, are also 
found in this layer (Romani et al., 2010). 
 
1.2.1.3. Stratum Granulosum (Granular layer) 
Moving from the spinous layer to the surface, keratinocytes flatten, lose their 
nuclei and cytoplasm, and contain granules of keratohyalin and lamellar 
bodies (McGrath and Uitto, 2016). The stratum granulosum is named for the 
keratohyalin granules contained in the cells that give them a granular 
appearance. Keratinocytes in this granular layer produce filaggrin and loricrin 
(Mehrel et al., 1990; Rice and Green, 1979). 
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1.2.1.4. Stratum Corneum (Cornified layer) 
 
 Stratum corneum is the outermost layer of the epidermis (Figure 1.1). It 
consists of flattened cells known as corneocytes, which lose their nuclei, 
cytoplasmic organelles and undergo cornification. Corneocytes are 
surrounded by a protein envelope formed by covalent crosslinking of soluble 
proteins precursors such as loricrin, involucrin and SPRRs by the 
transglutaminases family of enzymes and embedded into a lipid matrix, 
which protects them from the external environment (Eckert and Rorke, 1989; 
Eckert et al., 1993; Eckhart et al., 2013; Yoneda et al., 1992). These cells are 
shed overtime through the process of desquamation and replaced by new 
cells from the layers below (Proksch et al., 2008). This cellular progression 
from stratum basale to the skin’s surface occurs in about 30 days in humans 
(McGrath and Uitto, 2016). 
The epidermis is separated from the dermis by the basement membrane 
zone (BMZ) (Tsuruta et al., 2011), which consists mainly of collagens such 
as type IV and type VII collagens; and laminins such as laminin 332 (laminin 
5), laminin 311 (laminin 6) and laminin 511 (laminin 10) (McGrath and Uitto, 
2016). 
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1.2.2. Dermis 
 
The dermis is a tough and resilient layer of the skin (Figure 1.1), which 
protects the body against mechanical injury and helps in thermal regulation 
(Bensouilah, 2007). Cell types found in the dermis are mainly fibroblasts and 
other cell types namely mast cells, macrophages, telocytes and lymphocytes 
(Ceafalan et al., 2012; Costin and Hearing, 2007; Tobin, 2006). Fibroblasts 
synthesize collagens such as type I and type III collagens, elastin and 
structural proteoglycans such as versican (Olsen et al., 1989; Zimmermann 
et al., 1994). Fibroblasts in the dermis are involved in providing elasticity and 
tensile strength to the skin; and are also involved in wound healing. 
Telocytes are cells with a small oval-shaped body, from which emerge very 
long and thin prolongations known as telopodes.  These cells are frequently 
in contact with stem cells, blood vessels, nerve endings and sebaceous 
glands within the dermis (Ceafalan et al., 2012; Kang et al., 2015) and are 
involved in regulating these surrounding cells by releasing and exchanging 
exosomes (Edelstein et al., 2016). Mast cells are specialized cells that play 
an important role in both adaptive and innate immunity (Benyon, 1989).  
In addition, nerve, vascular, lymphatic networks and skin appendages such 
as hair follicles, sweat and sebaceous glands are located within the dermis. 
The dermis is divided into two layers: stratum papillare and stratum 
reticulare. 
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1.2.2.1. Stratum Papillare 
 
The superficial portion of this layer has ridge-like projections known as 
dermal papillae, which extend towards the epidermis, containing blood 
vessels and Meissner’s corpuscles, which are specialised mechanosensory 
end organs responsible for sensitivity to light touch. Meissner’s corpuscles 
are present in glabrous skin such as the palms of the hands (Fleming and 
Luo, 2013). This layer is characterised by thin, poorly arranged collagen 
fibres consisting of type I and type III collagens (Sorrell and Caplan, 2004). 
The papillary dermis nourishes the epidermis through the network of blood 
vessels found within it and is involved with thermoregulation of the skin. 
 
1.2.2.2. Stratum Reticulare 
 
This layer is thicker and extends from the base of the stratum papillare to the 
hypodermis. It serves as a boundary between the dermis and hypodermis. 
The reticular dermis has blood vessels and connective tissue that supports 
the skin. The collagen fibres found in this layer are well organised and 
consist primarily of type III collagen.  Hair follicles extend through the 
reticular dermis ending in the adipocyte rich hypodermis. Sebaceous glands, 
sweat glands, nerves are also found in the reticular dermis (Sorrell and 
Caplan, 2004). 
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1.2.3 Hypodermis (Subcutis) 
 
The hypodermis is the deepest layer of the skin (Figure 1.1). It is made up of 
fat tissue that lies below the dermis that insulates the body from cold 
temperatures and provides shock absorption. The main cell types found in 
the hypodermis are adipocytes, which are specialised fat cells that store 
energy as fat. There are two major types of adipocytes in mammals, white 
adipocytes, which are involved in storage of fat and brown adipocytes, which 
are involved in thermoregulation (Algire et al., 2013; McGrath and Uitto, 
2016). 
 
 
1.3. The Hair Follicle 
The hair follicle (HF) in mammals is involved in thermal insulation, physical 
protection, camouflage, excretion, sensation, social interaction, wound 
repair, dispersion of sweat and sebum (Ito et al., 2005; Schneider et al., 
2009). In addition, it also provides a protective niche for epithelial and 
melanocyte stem cells (Alonso and Fuchs, 2003; Nishimura, 2011; Yang and 
Cotsarelis, 2010). 
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1.3.1. Hair Follicle Anatomy 
 
The hair follicle (HF) is a complex structure that undergoes regeneration and 
regression through continuous cycles of growth and rest (Alonso and Fuchs, 
2006).  
The fully developed anagen hair follicle can be divided into three anatomical 
compartments consisting of the infundibulum, isthmus and the inferior 
segment. The infundibulum and isthmus  are permanent, while the inferior 
segment renews itself in each hair cycle (Randall and Botchkareva, 2009).  
The infundibulum lies above the entry to the sebaceous duct and merges 
with the interfollicular epithelium (Schneider and Paus, 2014). The isthmus is 
the short region between the point of attachment of the arrector pili muscle 
and the entry of the sebaceous gland duct. The isthmus harbours the bulge 
region, which contains hair follicle stem cells (HFSCs) (Cotsarelis et al., 
1990; Geyfman et al., 2014). The inferior segment consists of the 
suprabulbar area and the hair bulb. The suprabulbar area lies below the 
isthmus and above the hair bulb. The suprabulbar area comprises of three 
layers, from outermost to innermost, the outer root sheath, inner root sheath 
and hair shaft (Messenger et al., 2016). The hair bulb, contains the hair 
matrix that consists of actively proliferating keratinocytes and pigment 
producing melanocytes that surround the flask-shaped dermal papilla, which 
consists of specialised fibroblast-like cells embedded in an extracellular 
matrix rich in basement membrane proteins and proteoglycans (Messenger 
et al., 2016; Paus and Foitzik, 2004; Randall and Botchkareva, 2009). 
Activated matrix keratinocytes proliferate rapidly, move upwards and 
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differentiate to give rise to cells of the hair shaft, as well as the concentric 
layers of the Inner root sheath. Melanocytes transfer pigment into the 
developing hair keratinocytes to give the hair its colour. The epithelial portion 
of the hair follicle is separated from the surrounding dermis by a collagenous 
layer known as the dermal or connective tissue sheath (Figure 1.2).  
The outer root sheath extends from the epidermal basal layer and encloses 
the HF. The outer root sheath forms the bulge region between the insertion 
of the arrector pili muscle and duct of the sebaceous gland. The bulge has 
been identified as a reservoir of multipotent stem cells that are label-
retaining, slow cycling (Cotsarelis et al., 1990) and  can be identified by 
molecular markers such as K15, K19, CD200 (human), and CD34 (mouse) 
(Lyle et al., 1998; Michel et al., 1996; Morris et al., 2003; Ohyama et al., 
2006; Rittié et al., 2009).  
The inner root sheath consists of four layers, namely the cuticle, Huxley’s 
layer, Henle’s layer and companion layer (Schneider et al., 2009). The inner 
root sheath protects the hair shaft. The cells of the cuticle of the inner root 
sheath partly overlaps with cells of the cuticle of the hair shaft, anchoring the 
hair shaft tightly to the HF. Inner root sheath cells produce keratins1/10 and 
trichohyalin that strengthen the inner root sheath to support and mould the 
growing hair shaft, as well as guide its upward movement (Randall and 
Botchkareva, 2009).  
The Hair shaft consists of the cuticle, cortex and the medulla. The hair shaft 
cuticle covers the hair. It also protects and maintains the integrity of the hair 
shaft (Randall and Botchkareva, 2009).  
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The dermal papilla consists of densely packed specialised fibroblast-like cells 
of mesenchymal origin and is enclosed by the hair bulb. It determines the 
size of the hair bulb, diameter and length of the hair shaft and the duration of 
anagen (Krause and Foitzik, 2006; Schneider et al., 2009). 
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Figure 1.2 The Hair Follicle. (A) Vertical section of human anagen hair 
follicle (Shimomura, 2013) (B) Schematic drawing illustrating the concentric 
layers of the outer root sheath (ORS), inner root sheath (IRS) and  hair shaft 
in the bulb. The inner root sheath is composed of four layers: Companion 
layer (CL), Henle's layer, Huxley's layer, and the inner root sheath cuticle 
(DP: dermal papilla; IRS: inner root sheath; ORS: outer root sheath; CTS: 
connective tissue sheath). Adapted from (Schneider et al., 2009). 
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1.4. Hair Cycle 
 
Hair follicles undergo rhythmic changes through a growth phase known as 
anagen, a regressive phase known as catagen and a rest phase known as 
telogen (Figure 1.3). Although hair follicle cycling is regulated by numerous 
growth factors, cytokines, hormones and signalling pathways, some of which 
are produced by the hair follicle itself, it is an autonomous phenomenon that 
continues even in isolated hair follicles in organ culture (Langan et al., 2015; 
Schneider et al., 2009; Stenn and Paus, 2001). 
 
1.4.1. Anagen 
 
This is the growing phase of the hair follicle and is divided into 6 stages 
based on specific morphological criteria. During early phases, transient 
amplifying cells derived from the epithelial hair follicle stem cells in the bulge 
proliferate rapidly, envelop the dermal papilla, grow downwards into the 
dermis and differentiate to form the hair shaft and inner root sheath. In mid 
anagen, hair follicle melanocytes located in the hair matrix show pigment-
producing activity, and the newly synthesized hair shaft begins to develop. 
The synthesis of new hair shaft and pigmentation only occurs during anagen 
(Krause and Foitzik, 2006).  In late anagen, full restoration of the hair fibre-
producing unit is achieved, which is characterised by the formation of the 
epithelial hair bulb surrounding the dermal papilla, located deep in the 
subcutaneous tissue, and the newly formed hair shaft emerges from the 
skin’s surface (Krause and Foitzik, 2006; Müller-Röver et al., 2001; Paus and 
Cotsarelis, 1999; Randall and Botchkareva, 2009; Stenn and Paus, 2001). In 
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humans, almost 85 – 90% of scalp hairs are in this phase. Anagen can last 
up to two to six years in human scalp hair follicles (Buffoli et al., 2014).  
Epidermal-mesenchymal interactions are fundamental drivers of the hair 
cycle. During anagen, active signal exchanges occur between the epithelial 
cells of the hair bulb and the fibroblasts of the dermal papilla. Actively 
proliferating and post mitotic keratinocytes of the hair matrix express 
receptors and/or intracellular signalling components of a variety of signalling 
pathways, such as c-kit, c-met, FGFR2 and IGF-IR, while the corresponding 
ligands, such as SCF, HGF, FGF7, IGF-1 and STAT5 are expressed in the 
dermal papilla (Danilenko et al., 1995; Itami et al., 1995; Legrand et al., 
2016; Lindner et al., 2000). In addition, signalling components of Bone 
Morphogenetic proteins (BMPs), Wingless (WNT), Fibroblast growth factor 
(FGF), Sonic Hedgehog (SHH) and Transforming growth factor-beta (TGF-β) 
have been identified to regulate anagen induction and maintenance 
(Botchkarev et al., 2001; Greco et al., 2009; Myung et al., 2013; Plikus, 
2012). 
  
1.4.2. Catagen 
 
At the onset of catagen, proliferation and differentiation of hair matrix 
keratinocytes reduces dramatically, melanin production by melanocytes 
ceases, and hair shaft production is completed. During catagen, the hair 
matrix and dermal papilla involved in hair production are reduced to sizes 
that allow them to regenerate in the next hair cycle after receiving the 
appropriate stimulation. The hair follicle shortens in length by up to 70%. 
17 
 
Morphologically and functionally, catagen phase can be divided into eight 
sub-stages (Müller-Röver et al., 2001). During catagen, a specialised 
structure, the club hair is formed (Alonso and Fuchs, 2006; Schneider et al., 
2009). The keratinised brush-like structure at the base of the club hair is 
surrounded by epithelial cells of the outer root sheath and anchors the hair in 
the telogen follicle. During catagen, the dermal papilla is transformed into a 
cluster of quiescent cells that are closely adjacent to the regressing hair 
follicle epithelium and travels from the subcutis to the dermis/subcutis border 
to maintain contact with the distal portion of the hair follicle epithelium 
including the secondary hair germ and bulge. Catagen is characterised by 
several simultaneously occurring and tightly coordinated cellular programs 
(Randall and Botchkareva, 2009). The most important characteristic feature 
is a well-coordinated apoptosis occurring in the proximal part of the hair 
follicle. Apoptosis is regulated differently in each follicle compartment and 
distinct cell populations show different abilities to undergo apoptosis 
(Botchkareva et al., 2006). The majority of the follicular epithelial cells and 
melanocytes are very susceptible to apoptosis, while dermal papilla 
fibroblasts and the populations of keratinocytes and melanocytes selected for 
survival display a high resistance (Lindner et al., 1997).   
Catagen induction is modulated by various signalling components of Bone 
Morphogenetic proteins (BMPs), Fibroblast growth factor (FGF), and 
Transforming growth factor-beta (TGF-β) (Foitzik et al., 2000; Tsuji et al., 
2003). 
 At the end of this regression stage, the hair follicle enters telogen. 
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1.4.3 Telogen 
 
Telogen hair follicles are very short in length. They are characterised by a 
lack of pigment-producing melanocytes and the inner root sheath. Their 
compact ball shaped dermal papilla is closely attached to a small cap of 
secondary hair germ keratinocytes containing hair follicle stem cells (Randall 
and Botchkareva, 2009). During telogen, the hair shaft matures into a club 
hair that is shed from the follicle (Paus and Cotsarelis, 1999). This resting 
phase typically lasts for two to three months before hair follicles of the human 
scalp re-enter anagen and the cycle is repeated.  Telogen to anagen 
transition occurs at the activation of bulge stem cells to proliferate and form 
the new hair shaft. 
  
1.4.4 Exogen 
An additional phase of the hair cycle known as exogen involves the shedding 
of the hair shaft from the telogen follicle. It is an active process that is 
accompanied by the activation of proteolytic processes in the follicular root 
(Milner et al., 2002). Exogen is independent of telogen and anagen. Van 
Neste et al. showed that in human hair follicles, anagen and telogen hairs 
are firmly anchored to the follicle, while exogen hairs are passively retained 
within the follicles. In addition, exogen clubs do not retain remnants of the 
outer root sheath, in contrast to plucked telogen hairs (Van Neste et al., 
2007). 
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Figure 1.3 – Key stages of the hair cycle. The hair cycle is divided into 
three phases: anagen (growth phase), catagen (regression phase) and 
telogen (resting phase). APM: arrector pili muscle; DC, dermal condensate 
(green); DP: dermal papilla (green); HS: hair shaft (brown); IRS: inner root 
sheath (blue); MC: melanocytes; ORS: outer root sheath; SC: sebocytes 
(yellow); SG: sebaceous gland. Adapted from (Schneider et al., 2009). 
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1.5. Epigenetic mechanisms controlling skin and hair 
follicle development  
 
Epigenetics studies the stable and heritable alterations in gene expression 
that occur without alterations in DNA sequence (Berger et al., 2009; Jaenisch 
and Bird, 2003).  
Increasing evidence suggests that epigenetic modifications play crucial roles 
in mammalian skin development (Dauber et al., 2016; Driskell et al., 2011; 
Ezhkova et al., 2011; Sen et al., 2010; Sen et al., 2008). These modifications 
include DNA modifications, post translational histone modifications and 
Chromatin remodelling. 
 
1.5.1. DNA Modification 
 
DNA modification processes that control gene expression include DNA 
methylation and hydroxylmethylation. 
  
1.5.1.1. DNA Methylation 
DNA methylation has been studied extensively. It involves the addition of a 
methyl group from S-Adenosyl-methionine (SAM) at the 5ꞌ position of a 
cytosine within the genome by a family of enzymes known as DNA 
Methyltransferases (DNMTs) to form 5-methylcytosine (Feng et al., 2010). 
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DNA methylation is present in about 4-8% of the cytosine bases within the 
human genome, depending on the cell type (Lister and Ecker, 2009; Lister et 
al., 2009). Most DNA methylation occurs within CpG dinucleotides but it has 
been reported to occur outside the CpG context in human DNA (Lister et al., 
2009; Yan et al., 2011). Within the human genome, about 30 million CpG 
dinucleotides exist either in a methylated or an un-methylated state (Cocozza 
et al., 2011). 
DNA methyltransferases include DNMT1, DNMT3A, DNMT3B and DNMT3L. 
DNMTs are essential for establishing and maintaining DNA methylation 
patterns. During cellular replication, DNA methylation patterns are passed 
from parent to daughter cells. DNMT1 ensures that programmed DNA 
methylation patterns remain through cellular generations and is referred to as 
maintenance DNMT (Lei et al., 1996; Li et al., 1992). DNMT3A and DNMT3B 
catalyse the methylation of both unmodified cytosines and hemi-methylated 
cytosines producing new DNA methylation marks. They are referred to as de 
novo DNMTs (Okano et al., 1999). DNMT3L lacks catalytic activity and acts 
as a cofactor for both DNMT3A and DNMT3B (Goll and Bestor, 2005). DNA 
methylation is usually associated with gene repression but it has been 
demonstrated that it can also contribute to gene activation (Rishi et al., 
2010). DNA methylation represses gene expression either through inhibiting 
the recognition of DNA by transcription factors or facilitating the binding of 
methyl-CpG binding proteins to DNA (Klose and Bird, 2006). DNA 
methylation can contribute to gene activation through the creation of new 
binding sites on target genes for the recruitment of the transcription factor 
C/EBPα (Rishi et al., 2010). 
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DNMT1 is expressed in the basal layer, hair follicle ORS and matrix cells in 
human and mice. In epidermal tissues, DNA methylation patterns are 
essential for the maintenance of progenitor cells and tissue renewal (Sen et 
al., 2010). DNMT1 and UHRF1, a protein which form complexes with DNMT1 
and recruits it to hemi-methylated DNA (Bostick et al., 2007; Sharif et al., 
2007), are expressed in the basal layer of the epidermis and are down 
regulated during differentiation. Depletion of DNMT1 in human primary 
keratinocytes resulted in progressive tissue loss and premature 
differentiation (Sen et al., 2010). Epidermal deletion of DNMT1 in mice led to 
hyper-proliferation in the epidermis and progressive hair loss associated with 
increased p16INK4A expression and a prolonged telogen phase (Li et al., 
2012). 
 
1.5.1.2. DNA Hydroxymethylation 
For a long time, DNA methylation marks were thought to be stable but the 
removal of the methyl group from cytosine base has been reported. This 
epigenetic mark known as DNA hydroxymethylation shows that DNA 
methylation is reversible. The ten-eleven translocation (TET) protein family of 
enzymes consists of TET1, TET2 and TET3. TET protein family of enzymes 
catalyse the hydroxylation of 5-methylcytosine (5mC) to 5-
hydroxymethylcytosine (5hmC) in an iron (II), α-ketoglutarate and divalent 
oxygen dependent manner (Ito et al., 2010; Tahiliani et al., 2009). In addition, 
TET proteins also catalyse the demethylation of 5mC by the further oxidation 
of 5hmC to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), followed 
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by TDG-dependent base excision repair to unmodified cytosine (Figure 1.4) 
(He et al., 2011; Ito et al., 2011; Wu and Zhang, 2017).   
The role of DNA hydroxymethylation in mammalian skin development is 
unclear. 
 
 
 
 
 
 
 
 
24 
 
 
Figure 1.4 The cycle of active DNA demethylation. DNA 
methyltransferases (DNMTs) convert unmodified cytosine to 5-
methylcytosine (5mC). 5mC can be converted back to unmodified cytosine 
by TET-mediated oxidation to 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC), followed by excision of 
5fC or 5caC mediated by thymine DNA glycosylase (TDG) coupled with base 
excision repair (BER). Adapted from (Wu and Zhang, 2017) 
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1.5.2. Histone Modifications 
 
In mammals, genomic information is organised into chromatin. The basic unit 
of chromatin is the nucleosome which consists of 147bp of DNA wrapped 
around an octamer of two molecules each of four core histone molecules – 
H2A, H2B, H3 AND H4 (Margueron and Reinberg, 2010).  
These core histone molecules are subject to a variety of post-translational 
modifications (PTMs) mostly in their N-terminal tails. These histone PTMs 
include methylation, acetylation, phosphorylation, ubiquitination, sumoylation, 
ADP ribosylation, arginine deamination and proline isomerisation (Berger, 
2002; Botchkarev et al., 2012; Kouzarides, 2007). Histone PTMs have been 
identified as modifications involved in epidermal development.  
 
1.5.2.1. Histone Acetylation 
Histone acetylation involves the addition of an acetyl group from acetyl-
coenzyme A onto the ε-amino group of lysine catalysed by histone 
acetyltransferases (HATs). Histone acetylation neutralises the positive 
charge of lysine and this in turn weakens the interaction between the histone 
tail and DNA (Allfrey et al., 1964). In mammals, HATs are diverse and are 
grouped into at least 5 different families including  
1. HAT1 
2. GNAT family which includes Gcn5 and PCAF  
3. MYST family including members such as Tip60 
4. P300/CBP family which includes p300 and CBP  
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5. Rtt109 (Marmorstein and Trievel, 2009; Schneider et al., 2013). 
Histone acetylation is reversible. Histone deacetylases (HDACs) catalyse the 
removal of the acetyl group from lysine residue. In mammals, 18 HDACs 
have been characterized and grouped into the following 4 major classes:  
1. Class I HDACs (HDAC 1, 2, 3 and 8) are localised in the nucleus and 
are expressed ubiquitously in all cells.  
2. Class II HDACs (HDAC 4, 5, 6, 7, 9 and 10) are localised mainly in the 
cytoplasm but can also shuttle between the cytoplasm and the 
nucleus when needed. Their expression is cell-type specific. They are 
further divided into class IIa (HDAC 4, 5, 7 and 9) and class IIb (HDAC 
6 and 10). 
3. Class III HDACs include the nicotinamide adenine dinucleotide (+)-
dependent (NAD+-dependent) Sirtuins – SIRT 1 – 7. SIRT 1, 6, and 7 
are localised in the nucleus. SIRT2 is localised in the cytoplasm while 
SIRT3, 4 and 5 are localised in the mitochondria (Michishita et al., 
2005). 
4. Class IV contains only one member – HDAC 11 which is localised in 
the nucleus (de Ruijter et al., 2003). 
HATs catalyse the addition of acetylation marks to histone  leading to open 
chromatin and transcriptional activation whereas HDACs catalyse the 
removal of acetylation marks from histone leading to compact chromatin and 
transcriptional repression (Shahbazian and Grunstein, 2007)(Figure 1.5). 
The promoter region of active genes is enriched in H3K9ac, H3K18ac and 
H2B12ac while the coding region of the active gene is enriched in H4K12ac 
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and H4K16ac (Botchkarev et al., 2012; Wang et al., 2009). Histone 
acetylation levels are significant in keratinocyte-specific gene expression 
programs. For example, treatment of primary human keratinocytes with 
HDAC inhibitors - TSA and sodium butyrate induced growth arrest via 
reduction of the expression of the proliferation gene CDK1 and induction of 
the expression of differentiation markers involucrin and transglutaminase 1 
(Elder and Zhao, 2002; Saunders et al., 1999).  Conditional deletion of 
HDAC1 and HDAC2 in embryonic mouse skin resulted in defective 
proliferation and stratification in the epidermis and no hair follicle 
development with an increase in apoptosis via the regulation of p63 and p53 
(LeBoeuf et al., 2010). Consistent with this data, ablation of HDAC 1 and 
HDAC2 in adult mouse skin led to severe epidermal defects, disruption in 
hair follicle regeneration and homeostasis, abnormal pigmentation and 
spontaneous tumour formation with impaired Sin3A co-repressor complex 
function, increased level of c-Myc and p53 expression (Hughes et al., 2014; 
Winter et al., 2013). Also ablation of HDAC1 in a skin tumour model led to 
accelerated tumour development suggesting a tumour suppressor role for 
HDAC1 in skin (Winter et al., 2013).  In human keratinocytes, SIRT1 inhibits 
proliferation and promotes differentiation in vitro (Blander et al., 2009). 
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Figure 1.5 – Histone acetylation. A diagram showing the dynamics 
between transcriptional activation by HATs and transcriptional repression by 
HDACs. Adapted from (de Ruijter et al., 2003; Schneider et al., 2013). 
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1.5.2.2. Histone Methylation 
Histone methylation occurs on the side chains of lysines and arginines. 
Lysines may be mono-, di, or tri-methylated while arginine may be mono- or 
di-methylated. In addition, arginine can be di-methylated symmetrically or 
asymmetrically (Bannister and Kouzarides, 2011). Histone methylation is 
catalysed by histone methyltransferases (HMTs), while demethylation is 
mediated by demethylases (Wang et al., 2009). Here, lysine methylation is 
discussed further. 
Lysine methylation involves the transfer of a methyl group from S-adenosyl-
methionine (SAM) to a lysine’s ɛ-amino group. This transfer is catalysed by a 
group of lysine methyltransferases (HKMTs) containing the SET domain 
[Su(var), Enhancer of zeste, Tritotax]. This group of SET domain containing 
lysine methyltransferases is sub-grouped into 7 families – SUV39, SET1, 
SET2, EZ, RIZ, SMYD AND SUV4-20 and also includes a few orphaned 
members –SET7/9 and SET8 (Dillon et al., 2005). In humans, DOT1L, a 
HKMT that does not contain the SET domain has been identified (Feng et al., 
2002; Min et al., 2003a). 
Lysine methylation in the H3 molecule could be associated with either 
transcription activation or repression depending on the degree and site of the 
modification in the histone tail (Barski et al., 2007). In general, H3K9, H3K27 
and H3K64 methylation are associated with transcription repression, while 
H3K4, H3K36 and H3K79 methylation are associated with transcription 
activation. For example, the removal of the repressive mark H3K27me3 
during epidermal differentiation is mediated by the demethylase JMJD3 (Sen 
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et al., 2008). In the absence of JMJD3, the expression of differentiation 
markers such as KRT1, KRT10, IVL and S100A8 were repressed and 
epidermal differentiation was prevented (Sen et al., 2008).  The role of 
Setd8, a histone methyltransferase that catalyses the mono methylation of 
histone H4 at lysine 20 (H4K20me) in epidermal development was 
demonstrated in Setd8 null epidermis (Driskell et al., 2011). Ablation of Setd8 
in the epidermis resulted in impaired proliferation and differentiation via the 
regulation of p63 and p53 expression (Driskell et al., 2011).   
 
1.5.3 Polycomb group proteins 
 
Polycomb group (PcG) proteins, first identified in Drosophila melanogaster 
as crucial regulators of developmental processes, form chromatin 
remodelling complexes known as Polycomb Repressive Complex (PRC), 
which silence genes by chromatin compaction (Kennison, 1995). In 
mammals, they are classified into two groups based on their association with 
different classes of multimeric protein complexes, Polycomb Repressive 
Complex 1 (PRC1) and Polycomb Repressive Complex 2 (PRC2). The 
constituents of each complex may differ among organisms and may be cell 
type dependent, but their core subunits are conserved across organisms. 
PRC1 complex consists of CBX (CBX2-4-6-7-8), RING1 (RING1A/B), PCGF 
(PCGF1-6) and HPH (HPH1-3), while the PRC2 complex consists of 
Enhancer of zeste homolog 1 or 2 (EZH1 or EZH2), Suppressor of zeste 12 
(SUZ12) and Embryonic ectoderm development (EED) (Figure 1.6) (Connelly 
and Dykhuizen, 2017; Di Croce and Helin, 2013). The way these complexes 
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are recruited to chromatin to impact compaction and gene silencing is still 
being studied. In addition to the core PRC2 subunits, several accessory 
proteins have been identified that associate with PRC2. These accessory 
proteins may enhance PRC2 enzymatic activity and facilitate its recruitment 
to chromatin. These accessory proteins include RbAp48/p46, AEBP2, 
JARID2, PHF1, MTF2, PHF19, C17orf96 and C10orf12 (Li et al., 2010; 
Sarma et al., 2008; Zhang et al., 2011).  
PRC2 is the first of the two PRC complexes that is recruited to chromatin, 
where it catalyses the trimethylation of lysine 27 on Histone 3 (H3K27me3) 
through the activity of one of its components, EZH1/EZH2 (Cao et al., 2002; 
Shen et al., 2008), then the CBX component of PRC1 recognises the 
H3K27me3 histone mark and recruits PRC1 complex which assists in 
chromatin compaction and gene repression (Min et al., 2003b; Zhang et al., 
2012). Once PRC1 is bound to chromatin, it catalyses the mono-
ubiquitination of histone H2A at lysine 119 (H2AK119ub1) through the 
activity of its RING1 component leading to chromatin compaction (Wang et 
al., 2004). Interestingly, a non-canonical PRC1 without the CBX and HPH 
components have been reported (Schwartz and Pirrotta, 2014). This has 
opened the debate on how PRC1 and PRC2 are recruited to chromatin. 
There is evidence that demonstrates that PRC1-mediated mono-
ubiquitination of H2A at lysine 119 leads to the recruitment of PRC2 and 
H3K27 tri-methylation at an unmethylated CpG island (Blackledge et al., 
2014; Cooper et al., 2014). Another study also reports the recruitment of 
PRC2 by PRC1-mediated H2AK119ub1, but this was via the interaction of 
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PRC2 complexes containing AEBP2 and JARID2 with the H2AK119ub1 
mark (Kalb et al., 2014).     
These Polycomb protein complexes are crucial in the control of tissue 
development, stem cell maintenance, cell cycle progression, senescence, X 
chromosome inactivation and cancer (Bracken et al., 2007; Casanova et al., 
2011; Richly et al., 2011; Simon and Kingston, 2009). 
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Figure 1.6 - Composition and functions of the main Polycomb 
Repressive Complexes, PRC1 and PRC2. Adapted from (Connelly and 
Dykhuizen, 2017; Di Croce and Helin, 2013). 
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1.5.4 Polycomb Repressive Complexes in mammalian skin 
development and homeostasis 
Polycomb repressive complexes play important roles during skin 
development and homeostasis. In the human epidermis, PRC1 component 
CBX4 regulates proliferation and differentiation of epidermal progenitor cells 
while protecting them from senescence. It is therefore required for epidermal 
progenitor cell maintenance (Luis et al., 2011). CBX4 exerts its function on 
proliferation and differentiation via its E3-SUMO ligase activity and represses 
senescence in a PRC1-dependant manner via its chromodomain (Luis et al., 
2011). In mouse skin, Cbx4 also maintains epidermal progenitor cell identity 
and controls proliferation of epidermal keratinocytes via the regulation of 
non-epidermal lineage and cell-cycle inhibitor genes (Mardaryev et al., 
2016).   
Another PRC1 component BMI-1, also known as PCGF4, is expressed in the 
basal and suprabasal layers of human epidermis (Lee et al., 2008; Reinisch 
et al., 2007; Ressler et al., 2006). BMI-1 promotes keratinocyte proliferation 
and survival by increasing the expression of cyclin D1; and protects 
keratinocytes from apoptosis mediated by stress agents via regulating 
caspase activation and PARP cleavage (Eckert et al., 2011; Lee et al., 
2008). BMI-1 also controls keratinocyte senescence by regulating the 
INK4a/ARF locus (Cordisco et al., 2010; Ressler et al., 2006; Silva et al., 
2006). 
The core components of PRC2 are expressed in the epidermis. Studies in 
PRC2-null mouse epidermis shows that loss of PRC2 in epidermal 
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progenitors and hair follicle progenitors give rise to distinct skin phenotypes 
in the epidermis and HFs. In the epidermis, loss of PRC2 enzymatic activity 
(Ezh1/2-null) in epidermal progenitors resulted in accelerated epidermal 
barrier formation, epidermal hyper proliferation and promoted their 
differentiation to Merkel cells via the regulation of Sox2 (Bardot et al., 2013; 
Dauber et al., 2016; Ezhkova et al., 2009; Perdigoto et al., 2016) while in HF 
progenitors, loss of PRC2 resulted in an upregulation of the Ink4a/Ink4b/Arf 
locus genes leading to a reduction in HFSC proliferation and eventually 
degeneration of the hair follicles as a result of increased apoptosis (Dauber 
et al., 2016; Ezhkova et al., 2011).  
Jarid2, an accessory member of PRC2 is reported to be necessary for 
epidermal homeostasis in mouse. Mejetta et al reported that in mouse skin, 
HF stem and progenitor cells require Jarid2 for their activation, proliferation 
and differentiation (Mejetta et al., 2011).  
 
1.5.5 Polycomb Repressive Complexes in skin diseases and 
cancer  
The role of PRC subunits in the pathogenesis of skin diseases such as 
psoriasis and atopic dermatitis is not clear but increasing evidence suggests 
that they may be involved in the pathogenesis of these diseases. For 
example, EZH2 has been reported to be elevated in lesional psoriatic skin 
and Liu et al. speculated that overexpression of EZH2 in psoriatic skin blocks 
AP1 activity and prevents effective differentiation of epidermal cells (Liu et 
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al., 2011). Understanding the role of PRC2 subunit in the pathogenesis and 
progression of skin diseases remains to be elucidated.     
Skin cancer is among the most common cancers in the world. Skin cancers 
include melanoma and non-melanoma skin cancers, which are basal cell 
carcinoma (BCC) and squamous cell carcinoma (SCC). Increasing evidence 
suggests a role for PRC subunits in the development and progression of skin 
cancers. However, the mechanisms by which PRC subunits regulate skin 
tumorigenesis are unclear and the focus of ongoing research. Several PRC 
subunits have been reported to be upregulated in skin cancers. Analysis of 
skin tumours cells, cell lines and genetic mouse models have revealed 
overexpression of BMI-1 and EZH2 in SCC, BCC and melanoma (Adhikary 
et al., 2015; Adhikary et al., 2013; Lee et al., 2008; Mihic-Probst et al., 2007; 
Reinisch et al., 2007; Zingg et al., 2015), while SUZ12 is overexpressed in 
melanoma and BCC (Martín-Pérez et al., 2010). Interestingly, tumour 
initiating cells known as cancer stem cells, which were enriched for BMI-1, 
EZH2 and H3K27me3, have been identified in SCC (Adhikary et al., 2013). 
These skin cancer stem cells require EZH2 for their survival, migration, 
invasion and tumour formation (Adhikary et al., 2015). Zingg et al. 
demonstrated a role for EZH2 in promoting melanoma growth and 
progression using a genetic mouse model (Zingg et al., 2015). 
The elevated levels of PRC subunits in various solid tumours, including skin 
cancers, has led to the proposal that modulating their activities can be 
employed as a strategy for suppressing tumour formation. For example, in 
skin cancer cell lines, treatment with sulforaphane, DZNep and EGCG 
reduced the expression of EZH2 resulting in growth arrest and increased 
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apoptosis (Balasubramanian et al., 2010; Choudhury et al., 2011). Treatment 
of SCC-13 cells with small molecule inhibitors, such as GSK126, resulted in 
reduced tumour formation when injected in NSG mice (Adhikary et al., 2015).  
Interestingly, these commercially available small molecule inhibitors of PRC 
subunits can be employed as an approach in depleting PRC subunits activity 
in vivo and in vitro to study their distinct functional role in skin development, 
homeostasis, cancer and diseases. A better understanding of the role of 
PRC subunits in human skin development, homeostasis and cutaneous 
disorders could lead to the possible use of these small molecule inhibitors as 
a therapeutic strategy for modulating PRC activities in skin cancer and skin 
diseases in the future. 
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1.6 Aims and Objectives 
 Progress over the past decade using conditional skin KO mice as a model 
has clearly defined a role for PRC2 in epidermal stem cell maintenance, 
epidermal homeostasis and HF homeostasis. However, a role for PRC2 in 
human epidermal homeostasis and HF regeneration remains largely unclear. 
The aim of this project is to determine the role of PRC2 in human skin 
homeostasis and HF regeneration. This will be addressed by the following 
aims: 
1. Investigate the expression of a PRC2 subunit – EZH2 in human skin 
tissue, epidermal cells sorted from human epidermis, hair follicles and hair 
follicle stem cells by employing Immunofluorescence, cell culture, RT-qPCR 
and Western blot.  
2. To determine the target genes of EZH2 using RNAi approach and 
Microarray analysis 
3. To determine the functional role of PRC2 in regulating gene expression 
during terminal differentiation in human epidermis by modulating its activity 
utilising selective small molecule inhibitors or RNAi approaches. 
4. To evaluate the effect of modulating EZH2 activities using selective small 
molecule inhibitors or RNAi approaches on human hair growth ex vivo and 
primary hair follicle keratinocytes in vitro. 
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CHAPTER 2: Materials and Methods 
 
2.1 Ethics 
Keratinocytes and hair follicles were isolated and cultured from skin tissue 
from individuals undergoing cosmetic surgery (face lift) and hair transplant. 
Patients gave informed written consent and ethical approval was granted by 
the University of Bradford ethics committee. Skin tissue was prepared on the 
day of collection. 
  
2.2 Cell Culture 
2.2.1 Isolation of keratinocytes from adult skin  
  
Skin tissue specimen was obtained from facelift patients aged between 55 – 
67 years after undergoing cosmetic surgery (details in table 2.1). Skin 
samples were stripped of fat using scissors or razor blades and were cut 
up into approximately 1.0 cm2 pieces. Cut skin samples were thoroughly 
washed in PBS. Skin was incubated overnight submerged (epidermis side 
up) in 0.25% Trypsin at 4°C and then heated to 37°C for 30 minutes prior to 
removal of the epidermis. The epidermis was removed and incubated for 5 
minutes at 37°C in a water bath in 1 ml 0.05% Trypsin/0.02%EDTA (TE) and 
vortexed for 1 minute thereafter.  The resulting trypsinised cell suspension 
was carefully aspirated and transferred into serum-containing media to 
neutralise TE. Incubation in TE was repeated twice more. Cells-containing 
suspension was centrifuged for 5 minutes at 1000 RPM to pellet cells. The 
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cell pellet was re-suspended in KBM2/DMEM (ratio 2:1) and cells were 
seeded in T75 flask. DMEM (Gibco) supplemented with sterile 10% Fetal 
bovine serum (Gibco), 25mM HEPES (Gibco), 100 units/ml penicillin and 
100µg/ml streptomycin (Gibco), 2mM L-glutamine (Gibco) and 100mM 
sodium pyruvate (Gibco). Media was replaced with KBM2 medium 
(PromoCell) supplemented with 0.004ml/ml Bovine Pituitary Extract, 
0.125ng/ml recombinant human Epidermal Growth Factor, 5µg/ml 
recombinant human insulin, 0.33µg/ml hydrocortisone, 0.39µg/ml 
epinephrine, 10µg/ml transferrin and 0.06mM CaCl2 (PromoCell); two days 
after initial seeding and cells were fed every 2-3 days until sub-confluent. 
 
2.2.2 Isolation of keratinocytes from human hair follicles  
  
 Hair Follicles obtained from hair transplant surgery (details in table 2.1) with 
the top and dermal papilla cut off were put in DMEM (Gibco) supplemented 
with sterile 10% Foetal bovine serum (Gibco), 25mM HEPES (Gibco), 100 
units/ml penicillin and 100µg/ml streptomycin (Gibco), 2mM L-glutamine 
(Gibco) and 100mM sodium pyruvate (Gibco). Media was replaced with 
KBM2 medium (PromoCell) supplemented with 0.004ml/ml Bovine Pituitary 
Extract, 0.125ng/ml recombinant human Epidermal Growth Factor, 5µg/ml 
recombinant human insulin, 0.33µg/ml hydrocortisone, 0.39µg/ml 
epinephrine, 10µg/ml transferrin and 0.06mM CaCl2 (PromoCell); two days 
after initial seeding and cells were fed every 2-3 days until subconfluent. 
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2.2.3 Culturing and passaging of keratinocytes 
 
Cells in culture flasks isolated from adult skin, human hair follicles and 
juvenile foreskin obtained from Promocell (Promocell) were usually split 
when they reached between 80 and 90% confluence. Cells were washed 
under the safety cabinet with 5ml pre-warmed DPBS (Gibco). DPBS was 
removed and 5ml 0.5mM EDTA added flask was transferred to the incubator 
for 5 minutes to break cell-cell interaction. At this stage, the cells have 
become single cells and round. EDTA was removed and 3ml 0.05% 
Trypsin/0.02%EDTA (TE) added as above but for about 3 minutes. TNS 
(PromoCell GmbH) was added to cells to inactivate the activity of trypsin. 
Amount added was equal to the volume of TE. Cells were then transferred 
into 15 ml Falcon tube and centrifuged at 1500 RPM for 3 minutes. Cell pellet 
was either re-suspended in KBM2 medium or frozen as described below. 
Following resuspension in KBM2 medium, cells were counted immediately 
using Haemocytometer chamber and seeded for experiments or further 
culture. 
For analysing EZH1, EZH2 and cell cycle regulators expression in aged and 
young NHEKs, NHEKs pooled from adult keratinocytes isolated from female 
individuals aged 57 and 64 (Aged) and isolated from juvenile foreskin from a 
single donor (Young) (Promocell) were seeded at 2 x 105 cells and grown till 
60 -70% confluent. Media was changed to KBM2 medium without 
supplements for 24hrs for cell cycle synchronisation and switched back to 
complete KBM2 medium before treatment with EZH1/2 and EZH2 inhibitors. 
Cells were collected at day 3 or 4 after treatment for total RNA isolation. 
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2.2.4 Freezing and Thawing of keratinocytes 
 
Cell suspension obtained in the context of cell passaging was transferred to 
a 15ml Falcon tube and centrifuged at 1000 RPM for 3 minutes. Supernatant 
was discarded, and cell pellet was re-suspended in 1ml CryoSFM freezing 
medium (Promocell, UK) per 1-2 x106 cells. Cells were transferred into the 
freezing vial(s). The vial(s) was transferred into Mr. Frosty which was taken 
to the -80oC freezer overnight before cells were transferred into the liquid 
nitrogen (-196oC) for storage until needed.  
To thaw cells, vials containing the cells were left in 37oC water bath until 
almost completely thawed. Cells were transferred into already pre-warmed 
complete KBM2 medium in T75 culture flask (Corning Life Sciences) and the 
flask transferred into the incubator at 37oC, 5% CO2 for the cells to attach to 
the flask and to continue proliferating until ready for the next passage. 
 
2.3 Isolation of human hair follicles 
Scalp tissue specimen was obtained from facelift and hair transplant patients 
aged between 45 – 69 years after undergoing cosmetic surgery (details in 
table 2.1). Tissue samples containing more than 50 hair follicles were 
dissected into single hair follicles using surgical blade and forceps under a 
stereo dissecting microscope (Nikon, USA). Hair follicles considered to be in 
the anagen stage morphologically were used for hair follicle organ culture. 
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2.4 Hair Follicle organ culture 
Human scalp hair follicles were isolated and cultured in vitro, as described 
previously (Philpott et al., 1990). Briefly, dissected hair follicles were cut into 
small pieces of approximately 2.2mm in length from the bottom of dermal 
papillae and cultured in 24-well cell culture plates for 6 days in William’s E 
medium (Gibco) supplemented with 10µg/ml hydrocortisone (Sigma), 
10µg/ml insulin, 2mM L-glutamine (Gibco), 1µg/ml streptomycin and 
1000units/ml penicillin (Gibco) at 37°C in a 5% CO2 atmosphere. HFs were 
either transfected with siRNA targeted at EZH2 or treated with a small 
molecule inhibitor of EZH2 - DZNep. Images were taken of hair follicles on 
day 0 before transfection or treatment, day 3, 6 and 7 post treatment or 
transfection. Images were captured using a Nikon Eclipse TS100 Light 
microscope (Nikon Instruments Inc., USA) and Vicicam camera (VWR, UK). 
Hair follicle length was measured using ImageJ software (NIH Image 
analysis website http://rsb.info.nih.gov/ij/). 
 
 
 
 
 
 
 
 
  
 
44 
 
Donor ID Anatomical 
Site 
Sex Age Passage 
number 
Used For 
447 Facial skin Female 57 P3 – P5 Isolation/Culture 
of keratinocytes 
448 Facial skin Female 64 P3 – P5 Isolation/Culture 
of keratinocytes 
484 Facial skin Female 65 P3 – P5 Isolation/Culture 
of keratinocytes 
451 Facial skin Female 67 P3 – P5 Isolation/Culture 
of keratinocytes 
488 Facial skin Female 64 P3 – P5 Isolation/Culture 
of keratinocytes 
484 Facial skin Female 65 P3 – P5 Isolation/Culture 
of keratinocytes 
513 Facial skin Female 55 P3 – P5 Isolation/Culture 
of keratinocytes 
536 Facial skin Female 57 N/A IHC 
12562 Occipital 
scalp 
Male 55 P3 – P4 Isolation/Culture 
of ORS 
keratinocytes 
169 Occipital 
scalp 
Male 47 N/A HFOC 
391 Facial skin Female 52 N/A HFOC/IHC 
360 Occipital 
scalp 
Female 67 N/A HFOC 
368 Occipital 
scalp 
Male 69 N/A HFOC/IHC 
770 Occipital 
scalp 
Male 45 N/A HFOC 
1158 Occipital 
scalp 
Male 55 N/A HFOC 
 
Table 2.1 Origin of primary cells and hair follicles. Abbreviations used in 
table: IHC – Immunohistochemistry. HFOC – Hair follicle organ culture. ORS 
– Outer root sheath. N/A – Not applicable.  
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2.5 Cell and Hair follicle transfection 
NHEKs at 60–70% confluency was transfected with 50nM of siRNAs 
targeting EZH2 or non-targeting negative control (ON-TARGETplus 
SMARTpool siRNA – Human, Dharmacon, USA), EED or scrambled 
negative control (Origene, USA) using Lipofectamine RNAimax reagent 
(Invitrogen, USA) according to manufacturer’s instruction. After 24 - 72 
hours, cells were subsequently analysed for gene expression by RT-qPCR 
and/or Western blot analyses.  
For HFs, microdissected human anagen HFs were transfected with a mixture 
of siRNA against EZH2, provided as a single reagent (Accell SMARTpool – 
Human EZH2, Dharmacon) in organ culture and with non-targeting siRNA as 
negative control (Accell Red Non-targeting siRNA- Human, Dharmacon). 
Accell- modified siRNAs are used without transfection reagents in serum free 
conditions. siRNAs were re-suspended in complete William E medium at a 
final concentration of 1 µM for the pool of EZH2 siRNA or non-targeting 
siRNA and the mixtures were added to the cultured HFs. 96 hours after 
transfection half of the HFs (5-12) from each group were collected for RNA 
isolation to evaluate transfection efficiency. The other half were embedded in 
cryomatrix and snap frozen for immunohistochemical analysis. Images were 
taken at day 0, 3 and 7 of the experiment using a stereoscopic microscope at 
x2 magnification equipped with a Nikon Coolpix digital camera for 
morphological evaluation. Images were collected using the Visicam image 
analysis software. The siRNA sequences are listed in Table 2.2.  
 
46 
 
Table 2.2 siRNA Target Sequences 
siRNA Target Sequence (5’-3’) 
ON-TARGETplus SMARTpool 
siRNA EZH2 Human 
GAGGACGGCUUCCCAAUAA 
GCUGAAGCCUCAAUGUUUA 
UAACGGUGAUCACAGGAUA 
GCAAAUUCUCGGUGUCAAA 
ON-TARGETplus Non-targeting 
pool 
UGGUUUACAUGUCGACUAA 
UGGUUUACAUGUUGUGUGA 
UGGUUUACAUGUUUUCUGA 
UGGUUUACAUGUUUUCCUA 
Accell Human EZH2 siRNA-
SMARTpool 
UUAUGAUGGUUAACGGUGA 
GCUGAAGCCUCAAUGUUUA 
CCUCUAACCAUGUUUACAA 
UGUCUGGAAUCAAAGGAUA 
Accell Red Non-targeting siRNA UGGUUUACAUGUCGACUAA 
EED Trilencer-27 Human siRNA GGACCUAUGAUAGCAAUACGAGCCA 
CGCUGUCAGUAUAGAAAGUGGUACA 
CCCUGAUACACCUACAAACACGCCA 
Trilencer-27 Universal 
Scrambled Negative Control 
siRNA Duplex  
CGUUAAUCG CGUAUAAUACGCGUAT 
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2.6 Treatment of cells and hair follicles with EZH2 and/or 
EZH1/2 inhibitors 
NHEKs were treated with EZH2 and/or EZH1/2 inhibitors to analyse their 
effect on proliferation, differentiation and apoptosis.  GSK126 (EMD Millipore 
Corp, USA) was utilised as a selective small molecule inhibitor of EZH2 
(McCabe et al., 2012), UNC1999 (Tocris, UK) was utilised as a selective 
small molecule inhibitor of both EZH1 and EZH2 while UNC2400 (Tocris) 
was a negative control (Konze et al., 2013). Cells were seeded at an 
appropriate density in 6 or 12-well cell culture plates and treated with 
GSK126 at concentrations of 2 or 3µM, UNC1999 and UNC2400 at a 
concentration of 3µM. After 72 or 96 hours, cells were subsequently 
analysed for gene expression by qPCR and/or Western blot. 
For HFs, microdissected human anagen HFs were treated with DZNep at 
concentrations of 5µM and 10µM. Images were taken of hair follicles on day 
0 before treatment, day 3 and 6 after treatment. Images were captured using 
a Nikon Eclipse TS100 Light microscope (Nikon Instruments Inc., USA) and 
Vicicam camera (VWR, UK). Hair follicle length was measured using ImageJ 
software (NIH Image analysis website http://rsb.info.nih.gov/ij/). HFs were 
snap frozen and sectioned for use in Immunohistochemical analysis.  
 
2.7 Plasmid Construction and Amplification 
Human EZH2 cDNA (GenBank #BC010858) in pLenti-GIII-CMV-GFP-2A-
Puro vector was purchased from Applied Biological Materials Inc (Richmond, 
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BC, Canada) and used as template to produce blunt-end PCR products 
using Phusion™ DNA polymerase (New England Biolabs, UK) and the 
following PCR primers:  
F-5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCATGGGCCAGAC-
TGGGAAG-3′  
R -5′-GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAAGGGATTTCCAT-
TTCTC-3′.  
The resulting EZH2 cDNA was cloned in a pDONR™221 vector (Invitrogen), 
amplified by transformation in competent cells (Invitrogen) and sub cloned 
into destination vector pLKO.DEST.EGFP (Addgene plasmid #32684) using 
gateway™ cloning system (Invitrogen) as previously described (Radulovich 
et al., 2011). All constructs were verified by sequencing (University of 
Dundee DNA Sequencing and Services, Dundee, UK). 
 
2.8 Lentiviral particles production and cell culture 
For lentiviral particle production, HEK 293T cells were transfected with 
transfection complex made up of 2µg EZH2 expression vector DNA, lentiviral 
packaging mix (1.6µg psPAX2 [Addgene plasmid #12260], 500ng pMD2.G 
[Addgene plasmid #12259]) and 10µl PEI transfection reagent (Sigma-
Aldrich, Dorset,UK) in 400µl Opti-MEM (Gibco). Two days after transfection, 
the virus-containing cell culture supernatant was collected, filtered using 
0.45µm filter, concentrated by adding Peg-it™ virus precipitation solution 
(SBI, California, USA), incubated at 4°C overnight and centrifuged at 1500xg 
to pellet precipitated viral particles. The viral particles were aliquoted and 
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used for infection or stored at -80°C for later use. Transfection efficiency was 
evaluated 48 hours post transfection by the percentage of GFP positive cells 
using flow cytometry.  
NHEKs stably expressing EZH2 or GFP (control) were generated by seeding 
NHEKs in 6-well plates and incubating at 37°C with 5% CO2 until 60-70% 
confluent, then infected with EZH2 lentivirus or control lentivirus and 
polybrene (8µg/ml) and used for differentiation experiments. 
 
2.9 Keratinocyte differentiation assay 
Calcium has been identified as a trigger for keratinocyte differentiation (Pillai 
et al., 1988). NHEKs untreated, treated, transfected or infected were cultured 
in KBM2 medium containing 1.8mM CaCl2 for 24, 48 and 72 hours 
depending on the nature of the experiment. Control NHEKs were always 
cultured under low Ca2+ conditions (0.06mM CaCl2). Cells were subsequently 
analysed for gene expression by RT-qPCR and/or Western blot analyses. 
 
2.10 In vitro model of differentiated and undifferentiated 
NHEKs 
For the in vitro model for investigating the role of EZH2 in differentiated and 
undifferentiated human keratinocytes, juvenile keratinocytes (Promocell) 
were transfected with siRNA targeting EZH2 and treated with GSK126 in low 
Ca2+ medium (0.06mM). The medium was changedto a high Ca2+ medium 
(1.8mM) after 24hrs and cultured for another 48hrs. This was known as 
undifferentiated NHEKs (UD EZHi). A second group of juvenile keratinocytes 
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was cultured in high Ca2+ medium. After 24hrs cells were transfected with 
siRNA targeting EZH2 and treated with GSK126 andmaintained in high Ca2+ 
medium for another 48hrs. This was known as differentiated NHEKs (D 
EZHi). The control NHEKs were transfected with non-targeting siRNA under 
similar conditions (UD control and D control). Cells from all four groups were 
analysed 72hrs after the start of the experiment for gene expression by RT-
qPCR and Western blot analyses. 
 
2.11 Nuclear Extraction  
Nuclear extracts were prepared from NHEKs induced to differentiate in the 
presence of high Ca2+ by using EpiQuik™ Nuclear Extraction Kit (Epigentek 
Group Inc., Brooklyn, NY, USA) following the manufacturer's instruction. 
Briefly, nuclear pellets were prepared from adherent cells and suspended in 
extraction buffer containing DTT and protease inhibitor cocktail. Suspension 
was centrifuged for 10 minutes at 14,000 rpm at 4°C. Supernatant was 
transferred into Eppendorf tubes. Nuclear extracts were quantified using the 
Qubit protein assay kit and Qubit 2.0 fluorometer (ThermoFisher Scientific) 
following manufacturer’s instructions. Quantified nuclear extracts were either 
stored at     -80°C for future use or used immediately for HMTase activity 
assay. 
 
2.12 HMT catalytic activity detection 
 HMT activity was assayed by using EpiQuik™ Histone Methyltransferase 
Activity/Inhibition Assay Kit (H3-K27) (Epigentek, USA) following the 
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manufacturer's instruction. HMT activity was calculated by using the following 
formula:  
𝐻𝑀𝑇 𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦(𝑛𝑔 ℎ/𝑚𝑔)⁄ =
𝑂𝐷(𝑠𝑎𝑚𝑝𝑙𝑒 − 𝑏𝑙𝑎𝑛𝑘)
𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝑎𝑚𝑜𝑢𝑛𝑡(𝜇𝑔) × ℎ𝑜𝑢𝑟 × 𝑠𝑙𝑜𝑝𝑒
× 1000 
 
 
2.13 Immunocytochemistry 
To assess cell proliferation, 5-bromo-2’-deoxyuridine (BrdU) assay that is 
based on incorporation of BrdU into cellular DNA during cell proliferation and 
detection of phosphorylated histone 3 on serine 28 in mitotic cells was 
utilised. To assess apoptosis, activated caspase 3 detection in apoptotic 
cells was utilised. Briefly, NHEKs were seeded on 15X15mm sterile 
coverslips (Menzel Glaser) in 12 well plates and cultured in 1ml complete 
KBM2 medium (PromoCell GmbH). Coverslips were coated with collagen 
prior to apply growing cells. Cells were seeded at an appropriate density and 
grown until 60 - 70% confluence was achieved. Cells were either transfected 
with control siRNA and EZH2 siRNA at a concentration of 50nM or treated 
with GSK126, UNC1999 and UNC2400 at a concentration of 3µM. Cells 
were allowed to proliferate for 48 - 72 hours prior to fixation and 
permeabilization. Coverslips were incubated with antibodies directed against 
proliferation and apoptosis markers, FITC-Anti-Bromodeoxyuridine[BrdU] 
(Abcam), H3S28p (Cell signalling) and activated Caspase 3[Caspase 3a] 
(Abcam). Cell nuclei were stained using DAPI [4', 6-Diamidino-2-
phenylindole] (Vector Laboratories, UK) or Propidium iodide [PI] (Sigma). 
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Cells were visualized using a Nikon ECLIPSE 50i fluorescent microscope 
(Nikon Instruments Inc., USA) and analysed using Image Pro Express 
(Media Cybernetics). Images of coverslip mounted cells were taken at X40 
magnification (n=5). The percentage of positive proliferating or mitotic cells 
(BrdU+ or H3S28p+) and positive apoptotic cells (Caspase 3a+) were 
calculated from the total number of DAPI+ or PI+ cells. 
 
2.14 Protein concentration determination 
Protein concentrations in cell lysates were determined by Bradford assay 
(ThermoFisher Scientific, Cramlington, UK) using manufacturer's protocol. 
Titrated concentrations of bovine serum albumin (BSA) were used as 
standard. 5μl of standards and lysates were aliquoted into a flat bottomed 
96-well plate (Corning). 200μl Coomassie protein reagent was added to the 
wells. The intensity of colour change from violet red to blue indicated the 
amount of protein present. Absorbance was measured at 560nm using 
Magellan 6, 200 series (Tecan). 
 
2.15 Western Blot Analysis 
Keratinocytes cultured in 6-well plates were lysed with CelLytic M lysis buffer 
(Sigma-Aldrich) containing protease inhibitor cocktail (Roche Applied 
Bioscience, Rotkreuz, Switzerland) to prevent protein degradation. Protein 
concentration was determined by Bradford assay (ThermoFisher Scientific). 
Total protein was incubated in 4X Loading buffer (200mM Tris Base, pH6.8, 
40% v/v glycerol, 8% w/v SDS, 0.04% w/v bromophenol blue and 20% v/v 
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beta-mercaptoethanol) for 5min at 95°C. 20-30µg of total protein was 
separated according to their molecular weight using 10-12 % SDS-PAGE. 
Proteins were blotted onto Nitrocellulose membrane (GELifesciences) using 
the wet transfer method. Membrane was blocked in 3% w/v dried semi-
skimmed milk in 1XTBST (10mM Tris Base pH7.2, 0.15M NaCl and 0.1% v/v 
Tween-20) for 1 hour on a shaker at 4°C. Membrane was probed with 
primary antibodies (listed in table 2.3) in 1XTBST containing 3% w/v dried 
semi-skimmed milk overnight at 4oC with gentle shaking. HRP-conjugated 
secondary antibodies (listed in table 2.4) were used at 1:2000 in 1xTBST for 
1 hour at 4oC with gentle shaking. Membranes were incubated in Super 
Signal West Femto substrate (Thermo Scientific) for 5 minutes at room 
temperature and protein bands were detected using Chemidoc imaging 
system (Bio-Rad). Densitometric analysis was performed on western blot 
images using ImageJ software (NIH Image analysis 
website http://rsb.info.nih.gov/ij/). Quantification provided as the ratio to actin 
abundance as a normalization control. 
For a repeat Western blot for loading control, membranes were stripped at 
room temperature for 30 minutes using stripping buffer (25mM Glycine, 1% 
SDS, 0.02% Sodium Azide and 0.1% β-Mercaptoethanol) and blocked with 
3% w/v dried semi-skimmed milk in 1XTBST for 30 minutes prior to probing 
with primary and secondary antibodies (listed in tables 2.2 and 2.3). 
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2.16 Immunohistochemistry 
Cryosections (10µm-thick) were dried at room temperature for 10 minutes, 
encircled with ImmEdge hydrophobic barrier pen (Vector Laboratories, UK) 
and fixed for 10 minutes in Acetone or Acetone/Acetic acid (1:1 v/v) at -20°C 
or 4% v/v Paraformaldehyde (PFA) at room temperature depending on the 
primary antibody used. Slides were washed 3 times for 5 minutes at room 
temperature in 1X PBS. Slides were incubated at room temperature for 35 
minutes with either 2.5% w/v Bovine Serum Albumin (BSA) or 10% v/v 
Donkey serum. Primary antibodies (listed in Table 2.3) were diluted in 
blocking buffer consisting of 5% w/v Bovine Serum Albumin (BSA), 1% v/v 
Triton-X100 and 2% w/v Saponin in 1X PBS. 100µl of each primary antibody 
solution was added onto slides with tissue sections and incubated overnight 
at 4°C. Slides were washed 3 times for 5 minutes at room temperature in 1X 
PBS with 0.05% v/v Triton-X100. Relevant secondary antibodies (listed in 
Table 2.4) diluted in blocking buffer were used for detection of primary 
antibodies. Slides were incubated for 1 hour at 37°C, washed 3 times for 5 
minutes in 1X PBS with 0.05% v/v Triton-X100 and mounted with 
Vectashield mounting medium with DAPI (Vector Laboratories, UK) or 
Fluoroshield mounting medium (Abcam). Immunofluorescence was detected 
using a Nikon ECLIPSE50i fluorescence microscope (Nikon Instruments Inc., 
USA) and image analysis software, Image Pro Express (Media Cybernetics). 
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Table 2.3 Primary Antibodies and associate dilutions 
ANTIGEN APPLICA-
TION 
HOST DILUTION 
USED 
SUPPLIER 
EZH2 
#Ab3748 
 
IHC 
ICC 
WB 
Rabbit 1:250 
1:1000 
1:1000 
Abcam  
EZH1  
#SC-20347 
WB Goat 1:1000 Santa Cruz 
PCNA 
#2586 
IHC Mouse 1:100 Cell 
Signalling 
ACTIVE 
Caspase 3 
#Ab13847 
IHC 
ICC 
Rabbit 1:100/1:500 Abcam  
FITC-α BrdU 
#347583-7583 
ICC Rabbit 1:2000 Beckton 
Dickinson, 
USA  
Cytokeratin 1 
(K1) 
#Ab93652 
WB Rabbit 1:1000 Abcam 
Cytokeratin 10 
(K10)  
#M7002  
#Ab76318 
IHC 
WB 
Mouse 
Rabbit 
1:100 
1:2000 
Dako 
Abcam  
Cytokeratin 14 IHC Mouse 1:100 Abcam 
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(K14) 
 #Ab7800 
Cytokeratin 15 
(K15) 
#SC47697 
IHC Mouse 1:100 Santa Cruz 
Cytokeratin 19 
(K19)  
#V1074 
IHC Mouse 1:100 Biomeda 
Corp 
Loricrin 
#PRB-145P 
WB Rabbit 1:1000 Biolegend 
H3K27me3 
#9733s 
WB Rabbit 1:1000 Cell 
Signalling 
CD200 
#AF2724 
IHC Goat 1:100 R & D system 
Actin 
#Ab3280 
WB Mouse 1:2000 Abcam 
GAPDH 
#Ab8245 
WB Mouse 1:2000 Abcam 
α6-intergrin-
PE 
#555736 
FACS Rat 1:25 BD 
Pharmigen 
Sca1-FITC 
#11-5981-85 
FACS Rat 1:50 eBioscience 
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Table 2.4 Secondary Antibodies and associate dilutions 
ANTIBOD-
IES 
APPLICAT-
ION 
HOST/ 
SPECIFICITY 
DILUTION 
USED 
SUPPLIER 
Alexa 488 
#A11029 
IHC Goat α 
Mouse 
1:200 Invitrogen  
Alexa 555 
#A31572 
IHC 
ICC 
Donkey α 
Rabbit 
1:200 
1:1000 
Invitrogen 
HRP-
Conjugated 
#7074s 
WB Horse α 
Rabbit 
1:2000 Cell 
Signalling 
HRP-
Conjugated 
#7076s  
WB Horse α 
Mouse 
1:2000 Cell 
Signalling 
HRP-
Conjugated 
#R-21459 
WB Rabbit α Goat 1:2000 Life 
Technology 
 
2.17 Total RNA Isolation  
Total RNA was isolated from untreated, treated and transfected primary 
human epidermal keratinocytes or human hair follicles using the Direct-zol 
RNA MiniPrep kit (Zymo Research Corp, USA) following manufacturer’s 
protocol. Briefly, adherent cells were lysed directly in cell culture plates by 
adding 500 -1000µl of TRI Reagent (Zymo Research Corp), scraping cells 
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using a cell scraper and transferred into RNase-free tubes. Hair follicles were 
put in TRI Reagent and mechanically homogenized with a pestle. The 
homogenate from either adherent cells or human hair follicles was incubated 
at room temperature (RT) for 5 minutes to allow the complete dissociation of 
nucleoprotein complexes. Ethanol was added directly to the homogenate 
(1:1), vortexed to mix and loaded into Zymo-Spin IIC Column in a collection 
tube. After centrifugation at 14,000xg for 30 seconds, the column was 
transferred to a new collection tube. 400µl of RNA Wash Buffer was added to 
the column and centrifuged at 14,000xg for 30 seconds to wash the column. 
80µl of DNase I Reaction Mix was added directly to the Column matrix and 
incubated at RT for 15 minutes. 400µl of RNA PreWash Buffer was added to 
the column and centrifuged at 14,000xg for 30 seconds to wash the column. 
This wash was done twice. 700µl of RNA Wash Buffer was added to the 
column and centrifuged at 14,000xg for 2 minutes and the column was 
transferred to an RNase-free tube. RNA was eluted with 25 - 50µl of 
nuclease-free water. RNA was quantified immediately using a Nanodrop 
(ThermoFisher Scientific). Quantified RNA was used immediately for 
complementary DNA synthesis or stored at -80°C for use later. 
 
2.18 Complementary DNA (cDNA) Synthesis  
Following RNA quantification, complementary DNA (cDNA) was generated 
for each total RNA isolated using qPCRBIO cDNA Synthesis kit 
(PCRBiosystems Limited, UK) following manufacturer’s protocol. Each 20ml 
reverse transcription reaction mix contained 4µl of 5X cDNA synthesis mix, 
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1µl of 20X reverse transcriptase (RTase), total RNA (between 100ng and 
400ng) and nuclease-free water up to 20µl final volume. Tubes were briefly 
centrifuged and loaded into the Thermal Cycler (Eppendorf, UK) and the 
reverse transcription protocol started as follows: incubation at 42°C for 30 
minutes followed by incubation at 85°C for 10 minutes to denature the 
enzyme, reverse transcriptase. Synthesized cDNA samples were stored at -
20°C until analysed.  
 
2.19 Real-Time Quantitative PCR (RT-qPCR) Analysis 
RT-qPCR primers were designed using PRIMER3web design software and 
ordered from Sigma. All primers were optimised using human universal 
reference cDNA (Clontech) at six different temperatures – 60°C, 61°C, 62°C, 
63°C, 64°C and 65°C. Melting curves were compared to establish optimal 
annealing temperatures for each primer.  
Each 20µl real-time PCR reaction mix contained 2µl of cDNA, 10µl of 2X 
qPCRBIO SyGreen Hi-ROX mix (PCRBiosystems, UK), 4.8µl of nuclease-
free water (Gibco) and 3.2µl of forward and reverse primers (Listed in Table 
2.5).  
All real-time PCR amplifications were performed using StepOnePlus Real-
Time PCR System (Applied Biosystems, UK) with duplicate or triplicate 
samples for each gene of interest. GAPDH or YWHAZ was used as 
housekeeping gene for normalization. Data was exported to Excel and 
analysed according to the ΔCt method using a reference gene. 
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 Firstly, Ct values of each sample replicates were normalised using GAPDH 
or YWHAZ as a reference gene:   
ΔCt [normalised samples] = (Ct [GAPDH or YWHAZ] – Ct [Target]) 
Next, the linear conversion of the normalised samples ΔCt was calculated  
(2(-ΔCt)). The average of the 2(-ΔCt) values, SD, SEM were then calculated. 
  
Table 2.5 Real-Time quantitative PCR primers  
SEQUENCE 
DEFINITION 
SEQUENCE (5’ – 3’) ANNEALING 
T°C 
EZH2  F-CAGAAGTTGAACGTGGGCAA 
R-GTCCTCCACCAACCTCTTCA 
60°C 
EZH1  F-GAGTTGGTCGATGCCCTGAAT 
R-AGCATGTCGCTTTCTCTTTCTT  
62°C 
Keratin 1 (KRT1)  F-ACTTGACAACTTGCAGCAGG 
R-CAATGATGCTGTCCAGGTCG 
60°C 
Keratin 10 
(KRT10)  
F-TTCGGGCTCTGGAAGAATCAAAC 
R-GCAGGATGTTGGCATTATCAGTTG 
61°C 
Keratin 14 
(KRT14) 
F-GCCTGTCTGTCTCATCCTC 
R-CTGAAGCCACCGCCATAG 
61°C 
Keratin 15 
(KRT15) 
F-AAAGAAGGGCCTCCAACACA 
R-TCTCGGCCAGTGAGTTCTCC 
62°C 
Keratin 19  
(KRT 19) 
F-GTCGATCTGCAGGACAATCC 
R-CCGCGACTACAGCCACTACT 
62°C 
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Loricrin F-ACGGAGGCGAAGGAGTT  
R-CCAGGTAGGTTAAGACATGAAGG  
64°C 
RPTN F-TGAGTCACAAATCTACCAGTGGC 
R-ACTGTCCACAATAAGAGCCTGAT 
60°C 
FOXN1 F-CCTTCGAGGAGATCCCAGTG  
R-TAGGGGAGCCCGTTACACC  
62°C 
CXCL10 F-GTGGCATTCAAGGAGTACCTC  
R-TGATGGCCTTCGATTCTGGATT  
60°C 
SPRR3 F-GGCTGAACACCTCGACCTT  
R-GCTTCAAAGGATGCTGGACACAC  
61°C 
Keratin 13 
(KRT13) 
F-CCCCAGGCATTGACCTGAC  
R-GTGTTGGTAGACACCTCCTTG  
61°C 
TINCR F-TGTGGCCCAAACTCAGGGATACAT  
R-AGATGACAGTGGCTGGAGTTGTCA  
60°C 
FLG F-AAAGAGCTGAAGGAACTTCTGG  
R-AACCATATCTGGGTCATCTGG  
60°C 
CCND1 F-CAATGACCCCGCACGATTTC 
R-CATGGAGGGCGGATTGGAA 
61°C 
TAB2 F-CTCCTGGTGGTACAACTCGAC 
R-TGATTTGGCTGTTGAGATGAGG 
60°C 
TREM2 F-GAGAAATCCCCTTCCCACCC 
R-GTGTCTCTCAGCCCTGGCA 
60°C 
p16INK4A F-ATGGAGCCTTCGGCTGACT 
R-GTAACTATTCGGTGCGTTGGG 
62°C 
p19INK4D F-GATGTCAACGTGCCTGATGG 
R-CCCTGCGATGGAGATCAGAT 
62°C 
p14ARF F-GGGTTTTCGTGGTTCACATCC 61°C 
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R-CTAGACGCTGGCTCCTCAGTA 
 GAPDH  F- TTGAGGTCAATGAAGGGGTC  
R- GAAGGTGAAGGTCGGAGTCA  
61°C 
YWHAZ F-TTCTTGATCCCCAATGCTTC 
R-AGTTAAGGGCCAGACCCAGT 
61°C 
PCNA F-AGCCGAAACCAGCTAGACTT 
R-GATGAGGTCCTTGAGTGCCT 
60°C 
CD200 F-GAACCATGGGGTGGTGATCC 
R-GGCTGTACATAGACGGTGAGG 
63°C 
CD34 F-CAGGAGAAAGGCTGGGCGAA 
R-ATTCGGTATCAGCCACCACG 
63°C 
 
 
 
2.20 Fluorescent-Activated Cell Sorting Analysis (FACS) 
FACS analysis was performed as previously described (Jensen et al., 2013). 
Briefly, human skin strips were collected and subjected to 5mg/ml Dispase 
(Gibco) digestion overnight at 4°C followed by 0.25% trypsin for 14 minutes 
at 37°C with moderate shaking. Cell suspension was passed through a cell 
strainer, and cells were then stained with α6-integrin-PE (1:25) and Sca1-
FITC (1:50). Basal cells were sorted as Sca1 (+), a6-integrin (+) and 
suprabasal cells sorted as Sca1 (-), a6-integrin (-). The dead cell population 
was excluded by DAPI staining. Sorting was performed on Moflo XDP cell 
sorter (Beckman Coulter, Buckinghamshire, UK) at 35 psi with a 100-mm 
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nozzle and sorted cells were collected directly into Trizol™ LS (Life 
Technology) for total RNA isolation. 
 
2.21 Microarray and Bioinformatics Analysis  
Total RNA was extracted from the adult keratinocytes and juvenile 
keratinocytes 24 and 48 hours after EZH2 siRNA transfection as described 
above. Quality of total RNA was tested by capillary electrophoresis on an 
Agilent 2100 bioanalyzer (Agilent). Samples were sent to EMBL GeneCore 
for Affymetrix Microarray analysis (EMBL GeneCore, Germany). The Raw 
fluorescence intensity values were normalized applying quantile 
normalization and RMA background correction. ANOVA was performed to 
identify differential expressed genes using a commercial software package 
SAS JMP10 Genomics, version 6, from SAS (SAS Institute, Cary, NC, USA). 
A false positive rate of a=0.05 with FDR correction was taken as the level of 
significance. 
 
2.22 Statistical Analysis  
Data were analysed for statistical significance using analysis of variance 
(ANOVA) and compared columns using Bonferroni when the graph involves 
multiple comparison or t-test when data are normally distributed and only two 
sets of data are compared or Mann Whitney U test when data are not 
normally distributed and only two sets of data are compared on Graphpad 
prism statistical analysis software (GraphPad Prism 6, GraphPad Software, 
San Diego, CA).‘n’ represents the number of independent experiments done. 
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All data are expressed as either Means ± SD or Means ± SEM. Values of p< 
0.05 were considered significant.  *p< 0.05, **p< 0.01, ***p< 0.001, 
****p<0.0001. 
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Chapter 3: Polycomb Repressive Complex 2 is 
required for effective epidermal differentiation 
in human epidermis 
 
3.1 Introduction 
 
The human epidermis acts as a barrier protecting the body from the external 
environment, against fluid loss, toxic chemical exposure, infectious agents, 
mechanical damage and ultraviolet radiation (Costin and Hearing, 2007; 
Tobin, 2006). The formation of a stratified epidermis in humans is initiated 
during embryonic development and continues throughout the life time of 
individuals. This continuous stratification of the human epidermis involves a 
cascade of cellular events that includes keratinocyte proliferation, terminal 
differentiation, migration, autophagy and desquamation (Akinduro et al., 
2016; Watt et al., 1988; Zhang et al., 2015). Basal mitotically active 
keratinocytes expressing K5 and K14 exit the cell cycle and commit to a 
terminal differentiation programme that gives rise initially to the spinous 
keratinocytes expressing K1 and K10 and then granular keratinocytes 
expressing Loricrin and Filaggrin, which eventually undergo cornification to 
form corneocytes which desquamate from the topmost layer of the 
epidermis, the stratum corneum (Bowden et al., 1987; Watt et al., 1988).  
Polycomb repressive complex 2 (PRC2) is a chromatin repressor that plays 
significant role in the regulation of tissue development, stem cell fate control 
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and in a variety of diseases such as cancer (Margueron and Reinberg, 2011; 
Sauvageau and Sauvageau, 2010; Surface et al., 2010). Mammalian PRC2 
consists of core subunits embryonic ectoderm development (EED), 
suppressor of zeste 12 homolog (SUZ12) and enhancer of zeste homolog 
1/2 (EZH1/2). EZH1/2 is the methyltransferase component of PRC2 
responsible for catalysing the trimethylation of lysine 27 on histone H3 
(H3K27me3) repressive histone mark. EZH2 carboxyl-terminal Su(var) 3,9, 
enhancer of zeste, trithorax (SET) domain is the catalytic domain required for 
methyltransferase activity (Cao et al., 2002; Kuzmichev et al., 2002). EED 
and SUZ12 are required for proper HMTase activity of EZH2 (Cao and 
Zhang, 2004; Han et al., 2007; Montgomery et al., 2005; Pasini et al., 2004). 
Loss of function studies in mouse have revealed an essential role for PRC2 
as a regulator of differentiation in mammalian skin development (Bardot et 
al., 2013; Dauber et al., 2016; Ezhkova et al., 2011; Ezhkova et al., 2009; 
Perdigoto et al., 2016). Based on these findings, it has been hypothesized 
that PRC2 could also be an essential regulator of epidermal differentiation in 
humans. In this project, the role of PRC2 in human skin homeostasis is 
investigated by examining the roles of EZH1/2 and EED in keratinocyte 
proliferation, differentiation, apoptosis and aging in human epidermis. 
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3.2 Results 
 
3.2.1. EZH2 expression is upregulated in differentiating 
suprabasal keratinocytes in human epidermis 
 
To determine a potential role for EZH2 in human skin homeostasis, its 
expression pattern was evaluated in adult human skin tissues by utilising a 
wide range of methods, including Immunohistochemistry, 
immunocytochemistry, FACS and RT-qPCR analysis.  
Immunofluorescence analysis revealed that EZH2 is expressed in both basal 
and suprabasal keratinocytes of adult human epidermis with little or no 
expression in the dermis. Interestingly, EZH2 was more prominently 
expressed in K10+ suprabasal keratinocytes compared to K14+ basal 
keratinocytes (Fig. 3.2.1A-B).  
The nuclear expression of EZH2 was also confirmed in NHEKs cultured on 
coverslips in serum-free medium in vitro (Fig.3.2.1C). Growing NHEKs in 
serum-free medium prolong their proliferative state (Pillai et al., 1988).  
To further confirm EZH2 expression pattern in human epidermis, 
keratinocytes isolated from fresh human skin tissue was sorted by FACS 
using α6 integrin (CD49f) and Sca1 antibodies as described previously 
(Jensen et al., 2013). Basal keratinocytes were α6+, Sca1+ while suprabasal 
keratinocytes were α6- and Sca1-.  Expression of EZH2 and markers of the 
basal and suprabasal layers in FACS sorted basal and suprabasal 
keratinocytes were analysed by RT-qPCR analysis. EZH2 expression was 
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significantly upregulated in suprabasal keratinocytes compared to basal 
keratinocytes. Furthermore, K14, a marker of the basal layer was 
downregulated while K1 and Loricrin, markers of the suprabasal layer were 
upregulated in suprabasal keratinocytes compared to the basal keratinocytes 
(Fig. 3.2.1D), confirming the purity of the two populations of keratinocytes. 
Taken together, these results suggest that EZH2 expression is upregulated 
in differentiating suprabasal keratinocytes compared to their progenitors in 
the basal epidermal layer. 
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Figure 3.2.1. EZH2 expression is upregulated in 
differentiating suprabasal keratinocytes in human epidermis. 
(A-B) Double Immunofluorescence for EZH2 and K14 (A) and K10 
(B) showing EZH2 expression in K14+ basal keratinocytes but increased 
expression in K10+ suprabasal keratinocytes. (C) Immunostaining showing 
EZH2 nuclear expression in NHEKs grown on coverslips in serum-free 
medium. (D) RT-qPCR in FACS-purified human epidermal keratinocytes 
showing an upregulation of EZH2, KRT1, LOR and downregulation of KRT14 
in α6⁻ suprabasal keratinocytes compared to α6+ basal keratinocytes 
(Mean±SD; n=3; ****P<0.0001, **P<0.01, *P<0.05). Scale bars: (A-B) 50µm, 
(C) 100µm 
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3.2.2. EZH2 expression and enzymatic activity increases in 
differentiating keratinocytes in vitro 
To investigate a potential role for EZH2 in the control of keratinocyte 
differentiation, NHEKs were cultured in low (0.06mM) and high (1.8mM) Ca2+ 
medium for 24 hours, 48 hours and 72 hours.  In culture, NHEKs need 
between 0.03 – 0.15mM of Ca2+ to proliferate while elevated levels of Ca2+ 
above 1mM induce their differentiation (Pillai et al., 1988). Effects of elevated 
Ca2+ on gene expression were analysed by RT-qPCR and Western blot. 
A significant up-regulation of EZH2 expression was observed in 
keratinocytes cultured in high Ca2+ medium compared to the less 
differentiated keratinocytes grown in low Ca2+ medium after 72 hours (Fig. 
3.2.2A). Ca2+-induced differentiation was confirmed by the increased 
expression of K10 protein level in keratinocytes grown in high Ca2+ medium 
(Fig. 3.2.2B-C).  Expression of EZH2 protein level as well as H3K27me3 
level was increased in keratinocytes grown in high Ca2+   medium compared 
to keratinocytes grown in low Ca2+ medium (Fig. 3.2.2B-C). Furthermore, a 
concurrent upregulation of EZH1 protein level, another PRC2 component, 
was observed in keratinocytes grown in high Ca2+   medium compared to 
keratinocytes grown in low Ca2+ medium (Fig. 3.2.2B-C). 
In addition, the effect of Ca2+-induced keratinocyte differentiation on EZH2 
methyltransferase activity (HMTase Activity) was also evaluated utilising 
histone methyltransferase activity assay.  
A 3-fold increase in HMTase activity was observed in differentiated 
keratinocytes grown under the high Ca2+ condition for 72 hours compared to 
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the less differentiated keratinocytes grown in low Ca2+ condition (Fig. 
3.2.2D), suggesting that an increase in Ca2+ concentration might correlate 
with increased EZH2 enzymatic activity.    
Taken together, these results suggest that not only is EZH2 expression 
upregulated in differentiating keratinocytes but also EZH2 enzymatic activity.  
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Figure 3.2.2. EZH2 expression and enzymatic activity 
increases in differentiating keratinocytes in vitro. (A) RT-qPCR 
showing upregulation of EZH2 in differentiating keratinocytes during Ca2+ -
induced differentiation (Mean±SD; n=3; *P<0.05). (B-C) Western blot and 
densitometric analysis showing increased EZH2, H3K27me3, EZH1 and K10 
protein levels in differentiating keratinocytes during Ca2+ -induced 
differentiation. Actin was used as a loading control (Mean±SD; n=3, 
**P<0.01, ***P<0.001). (D) HMTase activity assay showing increased 
HMTase activity in differentiating keratinocytes during Ca2+ -induced 
differentiation. NHEK - Normal human epidermal keratinocytes. HMTase – 
Histone Methyltransferase 
73 
 
3.2.3 EZH2 controls epidermal differentiation by preventing 
the premature expression of differentiation genes in basal 
keratinocytes 
To assess whether EZH2 plays a role in epidermal differentiation, small 
interfering RNA (siRNA) targeting EZH2 was utilised to knockdown EZH2 
expression in NHEKs. Gene expression was analysed by RT-qPCR. 
RT-qPCR analysis revealed a marked increase in the expression of 
differentiation genes, KRT1 and LOR in EZH2-depleted keratinocytes 
cultured in low Ca2+ medium compared to keratinocytes transfected with a 
non-targeting siRNA (Control siRNA) grown under same conditions for 24 
hours and 72 hours after transfection (Fig.3.2.3A), suggesting that EZH2 is 
involved in regulating the expression of these differentiation genes in 
undifferentiated keratinocytes.  
To further assess the functional role of EZH2 in terminal differentiation, EZH2 
was silenced in undifferentiated keratinocytes utilising either siRNA or a 
small molecule EZH2 inhibitor GSK126 approaches. Transfected or treated 
Keratinocytes were either induced to differentiation by high Ca2+ conditions or 
maintained in low Ca2+ conditions 24hrs post transfection or treatment.  
Effect of EZH2 depletion on gene expression was analysed by RT-qPCR and 
Western blot 48 hours post transfection or treatment.  
RT-qPCR analysis revealed a significant upregulation of KRT1 and LOR 
expression in EZH2 depleted keratinocytes grown in low Ca2+ medium 
compared to the untreated or non-targeting siRNA transfected keratinocytes 
grown under same conditions (Fig.3.2.3B-C). In addition, a significant further 
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increase in the expression of KRT1 and LOR was observed in EZH2 
depleted keratinocytes upon Ca2+ - induced differentiation compared to the 
corresponding control (Fig. 3.2.3B-C).  
Transfection efficiency and Ca2+-induced differentiation was confirmed by 
reduced expression of EZH2 protein level and increased expression of K1 
and LOR protein levels in EZH2-depleted keratinocytes compared to the 
corresponding control upon Ca2+-induced differentiation (Fig. 3.2.3D-E). 
Taken together, these results suggest that EZH2 controls epidermal 
differentiation by preventing the premature expression of differentiation 
genes in basal keratinocytes. 
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Figure 3.2.3. EZH2 controls epidermal differentiation by 
preventing the premature expression of differentiation genes 
in basal keratinocytes. (A) RT-qPCR showing significant upregulation 
of differentiation markers KRT1 and LOR after EZH2 knockdown with siRNA 
in NHEKs (B-C) RT-qPCR showing marked upregulation of differentiation 
markers KRT1 and LOR during Ca2+ -induced differentiation after EZH2 
silencing with siRNA and a small molecule, GSK126 in NHEKs (Mean±SD; 
n=3, ns-not significant, ****P<0.0001, ***P<0.001, *P<0.05) (D-E) Western 
blot and densitometric analysis  confirming knockdown of EZH2 and showing  
upregulation of  K1 and LOR protein levels during Ca2+ -induced 
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differentiation after EZH2 knockdown with siRNA in NHEKs. Actin was used 
as a loading control (Mean±SD; n=3, **P<0.01, ***P<0.001). NHEKs- Normal 
human epidermal keratinocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
77 
 
3.2.4 Overexpression of EZH2 does not inhibit keratinocytes 
differentiation in vitro 
To further investigate its functional role in terminal differentiation, EZH2 was 
overexpressed in undifferentiated NHEKs utilising a lentiviral vector either 
expressing EZH or expressing GFP as a control.  
Infection efficiency was assessed by RT-qPCR, which revealed a 13-fold 
increase in EZH2 expression in EZH2-expressing keratinocytes compared to 
the GFP-expressing keratinocytes (Fig. 3.2.4A). However, EZH2 
overexpression did not lead to an increase in the expression of KRT1 and 
the lncRNA TINCR, while it resulted in a marked decrease in LOR 
expression compared to the corresponding control (Fig.3.2.4B), confirming 
earlier findings shown above that EZH2 prevents the premature expression 
of these genes. 
To investigate the effect of EZH2 overexpression on keratinocyte 
differentiation, NHEKs infected with EZH2 lentivirus were induced to 
differentiate by high Ca2+ condition 24 hours post infection. Infection 
efficiency and gene expression was assessed after 72 hours by RT-qPCR.  
RT-qPCR analysis revealed a 3-fold increase in EZH2 expression in EZH2-
expressing Keratinocytes grown in high Ca2+ medium compared to the 
corresponding control (Fig. 3.2.4C). In addition, a significant upregulation in 
the expression of KRT1, LOR and the lncRNA TINCR was observed in 
EZH2-expressing keratinocytes upon Ca2+-induced differentiation compared 
to the corresponding control (Fig. 3.2.4D), suggesting that overexpressing 
EZH2 does not block Ca2+-induced differentiation.  
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Taken together, these results suggest that overexpression of EZH2 in 
keratinocytes prevents the premature expression of differentiation associated 
genes but does not inhibit their ability to undergo Ca2+-induced 
differentiation. 
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Figure 3.2.4. Overexpression of EZH2 does not inhibit 
keratinocytes differentiation in vitro. (A) RT-qPCR showing a 13-
fold increase in EZH2 expression in  EZH2-expressing keratinocytes 
compared to GFP-expressing keratinocytes (control) (B) RT-qPCR showing 
no increase in expression of KRT1, LOR and the lncRNA TINCR in EZH2-
expressing keratinocytes compared to GFP-expressing keratinocytes 
(Mean±SEM, n = 3, P***<0.001) (C) RT-qPCR showing a 3-fold increase in 
EZH2 expression in  EZH2-expressing keratinocytes compared to GFP-
expressing keratinocytes (control) after Ca2+ -induced differentiation (D) RT-
qPCR showing upregulation of  KRT1, LOR and the lncRNA TINCR in  
EZH2-expressing keratinocytes compared to GFP-expressing keratinocytes 
upon Ca2+ -induced differentiation (Mean±SEM, n=3, P****<0.0001). EZH2 – 
EZH2 expressing Keratinocytes. GFP- GFP expressing keratinocytes 
(control). 
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3.2.5 EZH2 depletion mediates complex changes in gene 
expression program in primary keratinocytes  
To further explore mechanisms underlying the effects of EZH2 on 
keratinocyte differentiation, microarray analysis of the global gene 
expression in keratinocytes after EZH2 silencing was performed. Total RNA 
from EZH2 siRNA transfected either juvenile or adult human keratinocytes 
was collected at 24 and 48 hours post transfection. Microarray profiling was 
followed by RT-qPCR validation.  
Gene Ontology (GO) analysis revealed the alteration of pathways involved in   
keratinocytes differentiation, epidermis development, and keratinocytes 
proliferation (Fig. 3.2.4A). In addition, different classes of non-coding RNAs 
such as snoRNAs and rRNAs were differentially expressed in EZH2-depleted 
NHEKs (Fig. 3.2.4B). Interestingly, one of the upregulated ncRNA was the 
lncRNA TINCR (Tissue differentiation-Inducing Non-protein Coding RNA), 
which mediates keratinocyte differentiation (Kretz, 2013). 
Differentially expressed genes selected for microarray validation by RT-
qPCR included lncRNA Tissue differentiation-Inducing non-protein coding 
RNA (TINCR), Filaggrin (FLG), Small Proline Rich Protein 3 (SPRR3), 
Keratin13 (KRT13), Repetin (RPTN), Triggering receptor expressed on 
myeloid cells 2 (TREM2), C-X-C Motif Chemokine Ligand 10 (CXCL10), 
Forkhead box protein N1(FOXN1), TGF-beta activated kinase 1/MAP3K7 
binding protein 2 (TAB2) and Cyclin D1 (CCND1). 
Microarray validation by RT-qPCR analysis confirmed that the expression of 
TINCR, FLG, SPRR3, KRT13, RPTN, TREM2, CXCL10 and FOXN1 was up-
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regulated in EZH2 depleted NHEKs while the expression of TAB2 and 
CCND1 was downregulated (Fig. 3.2.4C-E). The changes in the expression 
of these genes in EZH2-depleted NHEKs compared to the control reflect 
their increased differentiated status. 
Taken together, these results suggest that EZH2 mediates complex changes 
in gene expression program in primary human keratinocytes.  
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Figure 3.2.5. EZH2 depletion mediates complex changes in 
gene expression program in primary keratinocytes. (A) Gene 
Ontology (GO) terms enriched in EZH2-depleted NHEKs (DAVID 6.8 
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bionformatic analysis of Affymetrix microarray data).  (B) Annotation of 
different classes of ncRNAs up-regulated and down-regulated in EZH2-
depleted NHEKs (C-E) RT-qPCR analysis of selected genes in EZH2-
depleted NHEKs showing changes in gene expression validating microarray 
data (Mean±SEM, n=3). NHEKs – Normal Human Epidermal Keratinocytes 
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3.2.6 EZH2 prevents the premature expression of terminal 
differentiation associated genes in undifferentiated basal 
keratinocytes and modulates the dynamics of differentiation 
in differentiated suprabasal keratinocytes 
As shown in data presented above, EZH2 expression is upregulated in 
suprabasal keratinocytes. However, silencing it led to premature expression 
of differentiation genes, KRT1 and LOR while overexpressing it did not inhibit 
Ca2+-induced differentiation. Based on these findings, it was investigated 
whether these different observations were due to EZH2 having different 
functional roles in undifferentiated basal and differentiated suprabasal 
epidermal keratinocytes, NHEKs transfected with siRNA targeting EZH2 
together with a small molecule EZH2 inhibitor GSK126 were induced to 
differentiate by high Ca2+ condition 24 hours post transfection and treatment 
while another set of NHEKs induced to differentiate by high Ca2+ condition 
were transfected and treated with siRNA and GSK126  24 hours post 
induction of differentiation  (Fig.3.2.6A). Transfection efficiency and gene 
expression was analysed by RT-qPCR and Western blot analyses.  
RT-qPCR analysis showed transfection efficiency of about 75 – 80% in both 
differentiated and undifferentiated keratinocytes (Fig. 3.2.6B). In addition, a 
significant upregulation in the expression of terminal differentiation 
associated genes: KRT1, KRT10, LOR, FLG and the lncRNA TINCR was 
detected in EZH2 depleted undifferentiated keratinocytes compared to 
EZH2-depleted differentiated keratinocytes (Fig. 3.2.6C), suggesting that 
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EZH2 depletion does not stimulate further differentiation in already 
differentiating keratinocytes. 
Ca2+-induced differentiation was confirmed by the increased expression of 
K10 protein level in both undifferentiated and differentiated keratinocytes, 
however, its expression was markedly increased in undifferentiated EZH2 
depleted keratinocytes (Fig. 3.2.6D). In addition, EZH2 protein level was 
observed reduced in EZH2 depleted differentiated and undifferentiated 
keratinocytes with a corresponding reduction in H3K27me3 level (Fig. 
3.2.6D). Interestingly, a higher EZH2 protein level was observed in 
differentiated keratinocytes transfected with a non-targeting siRNA compared 
to corresponding undifferentiated keratinocytes (Fig. 3.2.6B and D), 
confirming earlier data showing EZH2 highly expressed in differentiating 
keratinocytes.  
Taken together, these results suggest that EZH2 prevents the premature 
expression of terminal differentiation associated genes in undifferentiated 
basal keratinocytes and modulates the dynamics of differentiation in 
differentiated suprabasal keratinocytes. 
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Figure 3.2.6. EZH2 prevents the premature expression of  
terminal differentiation associated genes in undifferentiated 
basal keratinocytes and modulates the dynamics of 
differentiation in differentiated suprabasal keratinocytes (A) 
Schematic diagram showing EZH2 silencing in a model of undifferentiated 
and differentiated NHEKs (B) RT-qPCR showing EZH2 expression after 
EZH2 silencing in differentiated and undifferentiated NHEKs (C) RT-qPCR 
showing  significant upregulation of terminal differentiation genes  KRT1, 
KRT10, LOR, FLG and the lncRNA TINCR in EZH2 depleted undifferentiated 
vs differentiated NHEKs (Mean±SEM; n=4, ****P<0.0001) (D) Western blot 
87 
 
showing expression of EZH2, H3K27me3 and K10 in EZH2 depleted 
undifferentiated vs differentiated NHEKs. GAPDH was used as a loading 
control. UD - Undifferentiated NHEKs, D - Differentiated NHEKs, Control - 
Control siRNA, EZH2i - EZH2 siRNA+GSK126 
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3.2.7 EED knockdown leads to the early expression of 
differentiation associated genes in NHEKs 
EED, SUZ12 and EZH1/2 are core subunits of PRC2. Several lines of 
evidence suggest that EZH2 needs to form a complex with EED and SUZ12 
for it to effectively carryout its HMTase function (Brooun et al., 2016; Cao 
and Zhang, 2004). Based on these findings, the functional role of EED in 
keratinocyte differentiation was assessed; NHEKs were transfected with 
siRNA targeting EED. Transfection efficiency and gene expression were 
analysed by RT-qPCR analysis.  
RT-qPCR analysis confirms transfection efficiency and revealed a 
downregulation of EZH1 and EZH2 expression after EED knockdown (Fig. 
3.2.7A-C), suggesting destabilisation of EZH1/2 transcripts as has been 
shown in other cell types (Kim et al., 2013). Furthermore, a downregulation 
of KRT1 and upregulation of LOR, FLG and the lncRNA TINCR was 
observed in EED depleted keratinocytes compared to keratinocytes 
transfected with the non-targeting siRNA (Fig. 3.2.7D), suggesting that 
silencing EED induces the premature expression of these differentiation 
associated genes.  
Taken together, these results suggest that EED, like its other PRC2 
component, EZH2 also controls epidermal differentiation by preventing the 
premature expression of differentiation associated genes in basal 
keratinocytes. 
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Figure 3.2.7. EED knockdown leads to the early expression of 
differentiation associated genes in NHEKs (A) RT-qPCR 
confirming knockdown of EED in NHEKs (B-C) RT-qPCR showing the 
expression of EZH2 and EZH1 in EED deficient NHEKs (D) RT-qPCR 
showing downregulation of KRT1 expression and upregulation of LOR, FLG 
and the lncRNA TINCR in EED deficient NHEKs (Mean±SEM, n=3, 
****P<0.0001). NHEKs – Normal Human Epidermal Keratinocytes 
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3.2.8 Inhibition of both EZH1 and EZH2 does not alter the 
expression of terminal differentiation genes in NHEKs 
There is evidence that EZH1 can compensate for the loss of EZH2 (Ezhkova 
et al., 2011; Ezhkova et al., 2009). However, EZH1 is shown to be a weaker 
methyltransferase compared to EZH2 (Margueron et al., 2008). To begin to 
understand the molecular mechanisms involved in the role of EZH2 in 
epidermal homeostasis, we utilised small molecule inhibitors for EZH2 – 
GSK126, for both EZH1 and EZH2 – UNC1999 and an analogue designed 
as a control – UNC2400. The effect of the inhibition on terminal 
differentiation of keratinocytes was investigated by analysing the expression 
of genes implicated in the control of cell proliferation, terminal differentiation, 
apoptosis and senescence. 
RT-qPCR analysis revealed downregulation of EZH1 and EZH2 expression 
in keratinocytes treated with UNC1999; and downregulation of EZH2 
expression with an upregulation of EZH1 expression in keratinocytes treated 
with GSK126 compared to the keratinocytes treated with UNC2400 (control) 
(Fig. 3.2.8A). In addition, no significant changes in KRT1, LOR and FLG 
expression was detected in UNC1999 treated keratinocytes while 
upregulation in KRT1, LOR and FLG expressions was detected in GSK126 
treated keratinocytes compared to the UNC2400 treated keratinocytes (Fig. 
3.2.8B) suggesting that treatment with UNC1999 has no effect on the 
expression of differentiation genes.  
Furthermore, UNC1999 treatment of NHEKs resulted in a non-significant 
downregulation in the expression of cell cycle inhibitor p14ARF, non-significant 
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upregulation in the expression of p19INK4D, a cycle cell inhibitor  and no 
change in the expression of p16INK4A, a marker of senescence and cell cycle 
inhibitor compared to the UNC2400 treated NHEKs while GSK126 treatment 
of NHEKs resulted in a non-significant downregulation of p14ARF expression 
with a non-significant upregulation in the expression of p19INK4D and p16INK4A 
(Fig. 3.2.8C). 
In addition, cell proliferation was assessed in NHEKs treated with the small 
molecule inhibitors utilising immunostaining for the mitotic cell marker 
H3S28p.   Immunofluorescence analysis and quantification revealed a 
significant reduction in the percentage of H3S28p positive mitotic 
keratinocytes in both UNC1999 and GSK126 treated keratinocytes compared 
to UNC2400 treated keratinocytes (Fig. 3.2.8 D-E). 
Taken together, these results suggest that inhibition of both EZH1 and EZH2 
does not alter the expression of genes involved in terminal differentiation, 
apoptosis and senescence but reduces proliferation in NHEKs. 
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Figure 3.2.8. Inhibition of both EZH1 and EZH2 does not alter 
the expression of terminal differentiation associated genes in 
NHEKs (A) RT-qPCR showing the expression of EZH1 and EZH2 in 
NHEKs treated with UNC2400 (control), UNC1999 (EZH1and EZH2 inhibitor) 
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and GSK126 (EZH2 inhibitor) (B) RT-qPCR showing upregulation of KRT1, 
LOR and FLG expression in only  GSK126 treated NHEKs compared to the 
UNC2400 treated NHEKs (Mean±SEM, n=3, *P<0.05)  (C) RT-qPCR 
showing a not significant downregulation of  p14ARF in both UNC1999 and 
GSK126 treated NHEKs, not significant upregulation of p19INK4D expression 
in both UNC1999 and GSK126 treated NHEKs with no change in p16INK4A 
expression in UNC1999 treated NHEKSs but a not significant upregulation of  
p16INK4A expression in GSK126 treated NHEKs. (D) H3S28p staining 
showing reduced proliferation in NHEKs treated with UNC1999 and GSK126 
compared to NHEKs treated with UNC2400 (E) Quantification of percentage 
of H3S28p(+) NHEKs (Mean±SD; n=5, *P<0.05). Scale bars: 100µm. NHEKs 
– Normal Human Epidermal Keratinocytes 
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3.2.9 Loss of EZH2 leads to reduced proliferation and 
induces apoptosis in NHEKs 
To further understand the functional role of EZH2 in epidermal homeostasis, 
the effect of EZH2 depletion on keratinocyte proliferation and apoptosis was 
investigated, NHEKs were transfected with siRNA targeting EZH2 followed 
by analysis of proliferation and apoptosis by utilising 5-bromo-2’-deoxyuridine 
(BrdU) assay that is based on BrdU incorporation into cellular DNA during 
cell proliferation and activated caspase 3 detection utilising anti-BrdU and 
anti-Caspase 3a antibodies.  
Immunofluorescence analysis and quantification revealed a significant 
reduction in the percentage of BrdU positive proliferating keratinocytes and a 
significant increase in the percentage of activated Caspase 3 positive 
apoptotic keratinocytes in EZH2 depleted keratinocytes compared to the 
corresponding control (Fig. 3.2.9A-D), suggesting that EZH2 is required for 
proliferation and EZH2 depletion activates apoptosis.  
Taken together, these results suggest that loss of EZH2 leads to reduced 
proliferation and induced apoptosis in NHEKs. The effect on proliferation is 
similar to the negative effect on proliferation observed earlier in EZH1 and 
EZH2 depleted NHEKs.  
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Figure 3.2.9. Loss of EZH2 leads to reduced proliferation and 
induced apoptosis in NHEKs (A) BrdU staining showing reduced 
proliferation in EZH2 deficient NHEKs (B) Quantification of percentage of 
BrdU(+) NHEKs (Mean±SD; n=5, ***P<0.001) (C) Activated Caspase 3 
(Caspase3a) staining showing increased apoptosis in EZH2 deficient NHEKs 
(D) Quantification of percentage of Casp3(+) NHEKs (Mean±SD; n=5, 
***P<0.001). Scale bar: 100µm. PI - Propidium iodide  
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3.2.10 EZH2 expression is downregulated in aged NHEKs 
Data presented above show an increase in the expression of p16INK4A in 
EZH2 depleted keratinocytes. There is evidence that p16INK4A expression is 
upregulated in aging human skin (Ressler et al., 2006). To investigate if 
EZH2 has any role in human skin aging and senescence, NHEKs isolated 
from juvenile foreskin from a single donor (Young) and adult skin pooled from 
two female donors aged 57yrs and 64yrs (Aged) were treated with a small 
molecule EZH1 and EZH2 inhibitor UNC1999, small molecule EZH2 inhibitor 
GSK126 and a small molecule UNC2400 as control for four days.  
RT-qPCR analysis revealed a downregulation of EZH2 expression in aged 
NHEKs compared to young NHEKs treated with UNC2400, UNC1999 and 
GSK126 with no significant change in EZH1 expression in young NHEKs 
compared to aged NHEKs (Fig. 3.2.10A). In addition, over 2-fold increases in 
expression of senescence-associated genes p16INK4A and p19INK4D was 
observed in aged NHEKs compared to young NHEKs treated with UNC2400 
and GSK126 with no significant change in p14ARF expression in aged NHEKs 
compared to young NHEKs in all treatment groups (Fig.3.2.10B). 
Taken together, these results suggest that EZH2 is downregulated in aged 
NHEKs and this leads to the upregulation of the expression of senescence-
associated genes p16INK4A and p19INK4D. 
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Figure 3.2.10. EZH2 is downregulated in aged NHEKs (A) RT-
qPCR showing the expression of EZH1 and EZH2 in young and aged 
NHEKs treated with UNC2400 (control), UNC1999 (EZH1/2 inhibitor) and 
GSK126 (EZH2 inhibitor). (B) RT-qPCR showing significant upregulation of 
p16INK4A and p19INK4D expression in UNC2400, UNC1999 and GSK126 
treated aged NHEKs compared to young NHEKs treated with UNC2400 
(control) (Mean±SEM, n=3; **P<0.01, ***P<0.001, ****P<0.0001) 
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3.3 CONCLUSION 
Based on the data obtained from this study, the following conclusions can be 
drawn: 
1. In human epidermis, EZH2 is highly expressed in differentiating 
suprabasal keratinocytes. EZH1/2 expression and enzymatic activity 
increases during Ca2+-induced differentiation. EZH2 plays different 
functional roles in basal and suprabasal layers by preventing the 
premature expression of terminal differentiation associated genes in 
undifferentiated basal keratinocytes and modulating the dynamics of 
differentiation in differentiated suprabasal keratinocytes.  
2. Inhibition of EZH2 and EED in primary human keratinocytes in vitro 
leads to their premature differentiation by stimulating the precocious 
expression of differentiation-associated genes, K1, K10, LOR, FLG 
and TINCR. 
3. EZH2 overexpression in primary human keratinocytes prevents the 
premature expression of differentiation associated genes but does not 
inhibit their ability to undergo Ca2+-induced differentiation. 
4. EZH1/2 controls the balance between proliferation and apoptosis 
during epidermal homeostasis. 
5. Inhibition of EZH2 in epidermal keratinocytes induces complex 
changes in gene expression programmes, including the upregulation 
of genes involved in terminal differentiation, such as FLG and TINCR; 
and downregulation of genes involved in keratinocyte proliferation, 
such as CCND1. 
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6. EZH2 might play a role in epidermal aging by altering the expression 
of senescence-associated genes p16INK4A and p19INK4D. 
Taken together, the data obtained in this study suggest that in human 
epidermis, PRC2 is required for effective epidermal differentiation. PRC2 
also controls the balance between cell proliferation and apoptosis. PRC2 
may be involved in epidermal aging. Further research should be done to 
clearly understand the role of PRC2 subunits in epidermal aging. This 
study provides an important platform for further research into the 
possibility of modulating PRC2 activity as a new therapeutic strategy for 
disorders of epidermal differentiation.    
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CHAPTER 4: EZH2 is required for human hair 
growth 
 
4.1 Introduction 
Hair exerts diverse functions in mammals. These include thermal insulation, 
physical protection, camouflage, excretion, sensation, social interaction, 
dispersion of sweat and sebum (Schneider et al., 2009). In addition, it also 
provides a protective niche for several stem cell populations in the skin 
(Alonso and Fuchs, 2003; Yang and Cotsarelis, 2010). The hair follicle is 
composed of concentric layers that can be grouped into the outer root sheath 
(ORS), the inner root sheath (IRS), and the hair shaft (HS). The inner root 
sheath includes the companion layer, Henle’s layer, Huxley layer and the 
IRS cuticle while the hair shaft includes the cuticle, cortex and the medulla 
(Schneider et al., 2009). The cells in the hair follicle are either of epithelial 
origin or mesenchymal origin. The cells in the ORS, IRS, matrix and hair 
shaft are of epithelial origin, whereas the cells in the dermal papilla and 
connective tissue sheath are of mesenchymal origin (Yang and Cotsarelis, 
2010).  Hair follicles undergo cycles of growth (anagen), regression 
(catagen) and resting (telogen) phases. During hair cycling, stem cells 
residing in the bulge are responsible for hair regeneration (Blanpain and 
Fuchs, 2009; Cotsarelis et al., 1990).   
A role for PRC2 in regulating murine hair follicle development and 
homeostasis has been demonstrated in past studies (Dauber et al., 2016; 
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Ezhkova et al., 2011). However, the role of PRC2 in human hair follicle 
development and homeostasis remains unclear. In this study, the role of 
PRC2 in human hair homeostasis is investigated by examining the role of 
EZH2 in human hair growth. 
 
 
4.2 Results 
4.2.1 EZH2 is expressed in progenitor cells and 
differentiating cells in human hair follicles 
To determine a potential role for EZH2 in human hair growth, its expression 
pattern was assessed in human terminal anagen hair follicles by using 
immunofluorescence analysis.  
The prominent expression of EZH2 was observed in the outer root sheath 
(ORS), inner root sheath (IRS) and precortex whilst a weak EZH2 expression 
was seen in the dermal papilla (DP) and connective tissue sheath (CTS) 
(Fig. 4.2.1A), suggesting that EZH2 plays a predominate role in the epithelial 
compartments of anagen hair follicles. In addition, EZH2 expression was co-
localised with the follicular epithelial stem cell markers, such as CD200, K15 
and K19. Immunofluorescence analysis revealed EZH2 co-expression with 
CD200 in the follicular bulge (Fig. 4.2.1B), and with K15 and K19 in 
progenitor cells in the ORS (Fig. 4.2.1C-D). 
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Taken together, these results demonstrate that EZH2 is ubiquitously 
expressed in the hair follicle epithelium, including progenitor cells, suggesting 
a potential role for EZH2 in the control of PRC2-mediated gene expression 
programme during human hair growth.  
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Figure 4.2.1. EZH2 is expressed in progenitor cells and 
differentiating cells in human hair follicles. (A) 
Immunofluorescence analysis of human terminal anagen hair follicle showing 
the prominent expression of EZH2 in the outer root sheath (ORS), inner root 
sheath (IRS) and precortex with weak EZH2 expression in the dermal papilla 
(DP) and connective tissue sheath (CTS). (B-D) Immunofluorescence 
analysis showing EZH2 co-expressed with CD200 in the follicular bulge (B), 
with K15 and K19 in progenitor cells (C-D) in the ORS. Scale bars: 50µM. 
ORS – Outer root sheath 
104 
 
4.2.2 Inhibition of EZH2 activity in human hair follicles ex 
vivo results in hair growth retardation  
To investigate the functional role of EZH2 in human hair growth, activity of 
EZH2 was inhibited in human hair follicles ex vivo model utilising a selective 
small molecule, 3-Deazaneplanocin A (DZNep). DZNep is a S-adenosyl 
homocysteine hydrolase inhibitor which induces EZH2 depletion (Tan et al., 
2007). 
HFs were treated with either 5 or 10µM DZNep; effect of DZNep treatment 
on hair growth was evaluated by morphological analysis in comparison to the 
untreated control HFs. DZNep treatment resulted in reduced hair follicle 
length that was seen at day 3 and day 6 after the beginning of the 
experiment in a dose dependent manner compared to the untreated control 
(Fig. 4.2.2A-B). 
In addition, assessment of proliferation and apoptosis was performed using 
immunohistochemical analysis of DZNep treated and untreated HFs 
collected at day 6. Results revealed that the number of proliferating PCNA- 
positive cells were significantly reduced in DZNep treated HF in a dose 
dependent manner compared to the untreated control (Fig. 4.2.2C). The 
latter was associated with an increased number of apoptotic cells marked by 
active form of Caspase 3 in a DZNep dose dependant manner compared to 
the untreated control (Fig. 4.2.2D). This suggests that the hair growth 
retardation observed in DZNep treated HF was as a result of reduced 
proliferation and increased apoptosis in the ORS. 
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Taken together, these results suggest that inhibition of EZH2 activity with a 
selective small molecule DZNep results in hair growth retardation ex vivo 
associated with reduced proliferation and increased apoptosis in the ORS.  
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Figure 4.2.2. Inhibition of EZH2 activity in human hair follicles 
ex vivo results in hair growth retardation. (A-B) Inhibition of EZH2 
activity with a selective small molecule, DZNep, causes a dose-dependent 
retardation of hair growth ex vivo. (Mean±SD, n= 3 donors and 6 HFs for 
each treatment group, P*<0.05) (C) Immunohistochemical staining with anti-
PCNA antibody showing a dose-dependent decrease in proliferation (D) 
Immunohistochemical staining with anti-Caspase 3a antibody showing a 
dose-dependent increase in apoptosis in the ORS.  Scale bars: 50µM 
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4.2.3. Knockdown of EZH2 expression in human hair follicles 
ex vivo accelerates anagen to catagen transition 
To further investigate the functional role of EZH2 in hair growth, EZH2 
expression was knockdown in human hair follicle ex vivo model by utilising 
siRNA against EZH2. 
Effect of EZH2 siRNA on anagen-catagen transition was evaluated by 
morphological analysis. At day 7, about 38% of the HFs in EZH2 silenced 
group entered catagen compared to 13% in the control group (Fig. 4.2.3A-B). 
 The efficiency of silencing was evaluated by RT-qPCR and revealed that 
40% downregulation of EZH2 transcript was achieved (Fig. 4.2.3C). In 
addition, the effect of EZH2 silencing on proliferation and the expression of 
stem cell markers was assessed by RT-qPCR. The results revealed that the 
expression of the proliferation marker PCNA was significantly 
downregulated, stem cell markers CD200 and K15 were downregulated 
though not significant while the expression of stem cell marker K19 was 
significantly upregulated in EZH2 deficient HFs (Fig. 4.2.3D-E).   
Taken together, these results demonstrate that EZH2 silencing in hair follicle 
ex vivo accelerates anagen-catagen transition. These data confirm that 
EZH2 is required for keratinocyte proliferation and might be involved in the 
regulation of stem cell activity in human hair follicles.   
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Figure 4.2.3. Knockdown of EZH2 expression in human hair 
follicles ex vivo accelerates anagen to catagen transition (A) 
Knockdown of EZH2 expression with siRNA showing accelerated transition 
from anagen to catagen in HF ex vivo model transfected with EZH2 siRNA. 
(B) Quantification of HFs that entered catagen 7 days post transfection 
(Mean±SD, n=3 donors and 6 HFs for each treatment group, **P<0.01) (C) 
RT-qPCR showing silencing efficiency in HFs transfected with EZH2 siRNA 
collected at day 7 (D) RT-qPCR showing downregulation of PCNA 
expression in HF transfected with EZH2 siRNA compared to the control 
(Mean±SD, n=3, *P<0.05) (E) RT-qPCR showing down regulation of K15 and 
CD200 expression with significant upregulation of K19 expression in EZH2 
depleted HFs compared to the control (Mean±SD, n=3, **P<0.01).   HFs – 
Hair follicles.   
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4.2.4. Knockdown of EZH2 reduces proliferation and alters 
the expression of stem cell markers in ORSKs 
To further investigate EZH2 role in the regulation of hair growth, 
keratinocytes isolated from the ORS of human HFs (ORSKs) were 
transfected with EZH2 siRNA. Silencing efficiency was confirmed by RT-
qPCR that demonstrated reduced levels of EZH2 transcript in EZH2 siRNA 
versus scrambled siRNA transfected ORSKs (Fig. 4.2.4A). The effect of 
EZH2 silencing on keratinocytes proliferation was investigated by analysing 
the expression of genes implicated in the control of cell proliferation, 
apoptosis and senescence.  
Suppressed expression of EZH2 caused a significant downregulation of the 
expression of proliferation marker PCNA compared to the control (Fig. 
4.2.4B), consistent with earlier findings in NHEKs were EZH2 silencing led to 
their reduced proliferation. 
In addition, the evaluation of the effects of EZH2 silencing on the expression 
of stem cell markers showed negative regulation of CD200 expression, 
significant increase in K15 expression, while K19 and CD34 expression 
remained unchanged in EZH2 depleted ORSKs compared to the control (Fig. 
4.2.4C). Furthermore, the expressions of cell-cycle inhibitors such as p21, 
p16INK4A, p14ARF and p19INK4D were altered. Expression of p21 was 
downregulated though not significant and p16INK4A was significantly 
downregulated while expression of p14ARF was significantly upregulated with 
p19INK4D expression also upregulated though not significant in EZH2 depleted 
ORSKs compared to the control.  
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Taken together, these results demonstrate that EZH2 regulates proliferation 
at least in part via the INK4A/ARF locus and contributes to the control of 
stem cell activity in ORSKs.  
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Figure 4.2.4. Knockdown of EZH2 reduces proliferation and 
alters the expression of stem cell markers in ORSKs (A) RT-
qPCR showing knockdown efficiency in ORSKs transfected with EZH2 
siRNA  (B) RT-qPCR showing downregulation of proliferation marker, PCNA 
in EZH2-depleted ORSKs compared to the control (Mean±SD, n=3 
(triplicates), *P<0.05)  (C) RT-qPCR showing negative regulation of CD200 
expression and increase in K15 expression while the expression of K19 and 
CD34 remains unchanged in EZH2 depleted ORSKs compared to the control 
(Mean± SD, n=3, **P<0.01, ****P<0.0001) (D) RT-qPCR showing expression 
of cell cycle regulators in EZH2 depleted ORSKs (Mean±SD, n=3 
(triplicates), *P<0.005). ORSKs – Outer root sheath keratinocytes.  
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4.3 CONCLUSION 
Based on the data obtained from this study, the following conclusions can be 
made: 
1. PRC2 subunit EZH2 is ubiquitously expressed in epithelial cells of 
human anagen hair follicles. EZH2 is also expressed in follicular 
epithelial stem cells and progenitor cells.  
2. Inhibition of EZH2 activity in human hair follicles accelerates anagen-
catagen transition and retards hair growth. The hair growth retardation 
is associated with reduced cell proliferation and increased apoptosis 
in the outer root sheath. 
3. Inhibition of EZH2 in outer root sheath keratinocytes (ORSKs) results 
in the upregulation of senescence-associated gene, p14ARF and stem 
cell marker, K15. 
Taken together, the data obtained in this study suggest that EZH2 
prolongs anagen phase by promoting cell proliferation, at least in part via 
repressing the INK4A/ARF locus and represses apoptosis in outer root 
sheath cells. This study raises an avenue for further research into the 
possibility of modulating EZH2 activity as a new therapeutic strategy for 
hirsutism and hair loss disorders.    
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CHAPTER 5: DISCUSSION 
 
5.0 The Role of Polycomb Repressive Complex 2 
(PRC2) in epidermal homeostasis and hair growth  
In recent years, various studies have demonstrated a role for epigenetic 
mechanisms in mammalian skin development and homeostasis (Dauber et 
al., 2016; Driskell et al., 2011; Ezhkova et al., 2011; Ezhkova et al., 2009; 
Sen et al., 2010). For example, loss of function studies in mouse skin 
demonstrated a crucial role for PRC2 in regulation of proliferation, 
differentiation and apoptosis (Dauber et al., 2016; Ezhkova et al., 2011; 
Ezhkova et al., 2009).  Although, PRC2 has been studied extensively in 
murine skin development and homeostasis, its role in human skin 
development and homeostasis is still not well understood. This study 
demonstrated that PRC2 is involved in epidermal homeostasis and hair 
growth by regulating keratinocyte proliferation, epidermal differentiation, 
keratinocyte senescence, hair cycling and apoptosis. 
 
5.1 Changes in PRC2 activity during terminal differentiation 
of human epidermal keratinocytes 
In this study, for the first time, it was shown that EZH2 was highly expressed 
in differentiating suprabasal keratinocytes with weaker expression in 
undifferentiated basal keratinocytes in human epidermis. EZH2 was also 
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observed localised in the nucleus of cultured primary human keratinocytes; 
however, its expression was upregulated in differentiating keratinocytes upon 
Ca2+-induced differentiation. In addition, the expression of PRC2 subunit 
EZH1, a homolog of EZH2, as well as H3K27me3 levels was increased upon 
Ca2+-induced differentiation. This data somehow contradicts with a previous 
study that reported an EZH2 abundant expression in undifferentiated basal 
keratinocytes compared to suprabasal keratinocytes in adult human 
epidermis (Gannon et al., 2015). In addition, Gannon et al also reported that 
they observed no change in EZH2 protein level upon Ca2+-induced 
differentiation in primary human keratinocytes compared to undifferentiated 
proliferating keratinocytes. However, this conclusion made by Gannon et al., 
contradicts their own western blot data, which clearly shows a marked 
increase in EZH2 protein expression in Ca2+ treated differentiating 
keratinocytes compared to undifferentiated cells (Figure 1b, Gannon et al., 
2015).  The differences observed between the data obtained from this study 
and Gannon’s study in EZH2 expression pattern in adult human epidermis 
might be due to differences in detection methods used, for example, different 
anti-EZH2 antibodies used for immunostaining and western blot.  However, 
the conclusion from this study was drawn from data obtained using a wide 
range of methods including immunofluorescent staining, RT-qPCR of FACS-
sorted and cultured primary cells and Western blot analyses (Fig. 3.2.1 and 
3.2.2). Interestingly, this study for the first time revealed several notable 
differences in EZH2 expression pattern in adult mouse epidermis versus 
adult human epidermis. In contrast to human skin, Ezh2 expression waned 
with age in basal keratinocyte and was barely detectable in suprabasal 
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keratinocytes in adult mouse epidermis, as well as was downregulated upon 
Ca2+-induced differentiation of primary mouse keratinocytes (Ezhkova et al., 
2009). Based on these notable differences observed, we can speculate that 
EZH2 may have different functional roles in human and mouse epidermis.    
For decades, elevated calcium levels have been confirmed to be a trigger for 
keratinocyte differentiation both in vitro and in vivo (Bikle et al., 1996; Elias et 
al., 2002; Hennings et al., 1980; Menon et al., 1985; Pillai et al., 1990). As 
H3K27me3 and EZH2 transcript and protein levels were elevated in 
differentiating keratinocytes both in vivo and in vitro, EZH1/2 
methyltransferase activity upon Ca2+-induced differentiation in human 
primary keratinocytes was investigated. Interestingly, the methyltransferase 
activity was increased by 3-fold in differentiating keratinocytes compared to 
undifferentiated control cells. As the increase in methyltransferase activity 
could solely be attributed to the increase in EZH1/2 transcripts and protein 
levels, future studies are required to address if the intrinsic enzymatic activity 
of EZH1/2 also changes in differentiating human keratinocytes. 
Nevertheless, a direct correlation between elevated calcium level and 
increased K27 tri-methylation of Histone H3 suggests that PRC2 is involved 
in controlling gene expression not only in the basal layer but also in 
suprabasal cells. Ezhkova et al. demonstrated that Ezh2 functions in mouse 
basal progenitors, by mediating the repressive mark H3K27me3 on 
epidermal differentiation genes and preventing their activation by the 
transcription factor AP1 (Ezhkova et al., 2009). To explain the differences in 
the expression pattern of EZH2 between mouse and human epidermis, we 
have to bear in mind that human epidermis, unlike to mouse, is much thicker 
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due to significantly more layers of differentiating cells in each epidermal 
strata. We speculate that the complexity of human epidermis requires a more 
broader EZH2 expression pattern to control expression of epidermal 
differentiation genes in a temporal and spatial manner to correctly execute 
the terminal differentiation programme. Increased PRC2 activity may also be 
required to silence genes involved in the epidermal progenitor cell 
maintenance and proliferation in the differentiating keratinocytes. Future 
studies are essential to address these questions.  
    
5.2 PRC2 is involved in the regulation of terminal 
differentiation in human epidermis 
The main functions of PRC2 are establishing the repressive histone mark 
H3K27me3 and recruiting PRC1 to chromatin leading to PcG-mediated gene 
repression by chromatin compaction and interfering with transcription (Cao et 
al., 2002; Francis et al., 2004; Min et al., 2003b). EZH2 as the 
methyltransferase subunit of PRC2 is at the centre of this PcG-mediated 
gene repression. Increasing evidence indicates that PRC2 subunits are 
critical for the terminal differentiation of different cell types including skeletal 
muscle cells (Juan et al., 2011; Mousavi et al., 2012), epidermal cells (Bardot 
et al., 2013; Dauber et al., 2016; Ezhkova et al., 2009) and heart cells (He et 
al., 2012). In this study, a role for PRC2 in regulating terminal differentiation 
program in human epidermis using primary human keratinocytes (Normal 
Human Epidermal Keratinocytes - NHEKs) as a model was defined. Using a 
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wide range of experimental approaches, it was demonstrated that PRC2 
represses an array of genes involved in the terminal differentiation 
programme of primary human epidermal keratinocytes. To examine the role 
of PRC2 in keratinocyte differentiation, siRNA and selective small molecules 
were used to disrupt EZH2, EED and both EZH1/2 activities in NHEKs in 
vitro. This investigation revealed that silencing EZH2 or EED results in 
precocious expression of early and late differentiation genes (KRT1, LOR 
and FLG) and the differentiation-associated lncRNA TINCR (Kretz et al., 
2013) in undifferentiated NHEKs cultured in low calcium medium. 
Interestingly, Ca2+-induced differentiation of EZH2-depleted NHEKs leads to 
a significantly greater expression of terminal differentiation genes (KRT1, 
LOR, FLG and TINCR) compared to control cells.  These data are consistent 
with earlier studies, which demonstrated that the depletion of PRC2 subunits 
EZH2 and SUZ12 in epidermal progenitor cells results in premature 
expression of epidermal differentiation-associated genes (Ezhkova et al., 
2009; Sen et al., 2008). Previous studies in mouse adult epidermis suggest 
that EZH1 may compensate for the loss of EZH2 (Ezhkova et al., 2011; 
Ezhkova et al., 2009). This was tested by disrupting EZH1 and EZH2 
activities in NHEKs. Interestingly, inhibition of EZH1 and EZH2 activities in 
NHEKs simultaneously did not have any significant effect on the expression 
of differentiation-associated genes compared to the control. This is 
consistent with previous studies done in Ezh1/2 double knockout mice, 
where no epidermal defects where observed in postnatal skin (Dauber et al., 
2016; Ezhkova et al., 2011) suggesting that simultaneous ablation of Ezh1 
and Ezh2 in mice does not accelerate epidermal differentiation or epidermal 
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barrier formation.  EZH1/2 are the only PRC2 subunits that have 
methyltransferase capabilities, however, EZH1 is a weaker 
methyltransferase compared to EZH2 (Margueron et al., 2008; Shen et al., 
2008) and PRC2-EZH1 may target different sets of genes from PRC2-EZH2 
in the human epidermis.  Therefore, molecular events or pathways that 
compensate for the loss of EZH1 and EZH2 activities in epidermal 
keratinocytes, though beyond the scope of this project objectives, remains to 
be elucidated.    
EZH2-depleted keratinocytes express higher levels of differentiation 
associated genes (Ezhkova et al., 2009; Sen et al., 2008). Therefore, EZH2 
is important in regulating keratinocyte differentiation. To test this hypothesis, 
the effect of overexpression of EZH2 on keratinocyte differentiation was 
investigated. A lentivirus was utilised to overexpress EZH2 in NHEKs and 
differentiation was induced. Surprisingly, EZH2-overexpressing NHEKs that 
were induced to differentiate under high Ca2+ conditions underwent 
differentiation similar to the control cells, suggesting that EZH2 does not 
block terminal differentiation in differentiating cells. Results showed 3-fold or 
higher changes in expression of differentiation associated genes (KRT1, 
LOR, and TINCR) in EZH2-overexpressing keratinocytes versus the control 
keratinocytes upon Ca2+-induced differentiation, similar to EZH2-depleted 
NHEKs upon Ca2+-induced differentiation. This data is contrary to 
observations in various cancers where overexpression of EZH2 is associated 
with inhibition of differentiation. There is evidence that all three core PRC2 
subunits are overexpressed in small cell lung cancer (Sato et al., 2013) and 
colorectal cancer (Liu et al., 2015). We are tempted to speculate that EZH2 
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overexpression in NHEKs without simultaneous overexpression of the other 
core subunits of PRC2, EED and SUZ12, renders PRC2-mediated 
repression of differentiation genes ineffective in NHEKs.  
By employing microarray approach, gene expression profiles were compared 
between EZH2-depleted NHEKs and NHEKs transfected with a non-targeting 
control. As expected, depletion of EZH2 resulted in a higher percentage of 
gene upregulation in NHEKs. The microarray and RT-qPCR analyses 
showed changes in expression of genes involved in the control of 
keratinocyte differentiation, epidermis development, keratinocyte 
proliferation, cell cycle arrest and WNT signalling. Importantly, EZH2-
depleted keratinocytes showed marked increase in expression of genes 
involved in keratinocyte differentiation such as TINCR, FLG, FOXN1, KRT13 
and RPTN, while the expression of CCND1, involved in keratinocyte 
proliferation, was decreased. This confirms the differentiated status of EZH2-
depleted keratinocytes. 
Previous studies reported that EZH2 is highly expressed in proliferative cells 
and reduced in differentiating cells in mouse epidermis and other tissues 
(Ezhkova et al., 2009; Margueron et al., 2008). However, data obtained from 
this study has confirmed EZH2 highly expressed in differentiating cells of the 
human epidermis both in vitro and in vivo. We speculate that EZH2 has 
different functional roles in basal and suprabasal keratinocytes in human 
epidermis.  This hypothesis was tested by developing an in vitro model for 
studying the effects of EZH2 depletion in undifferentiated basal and 
differentiated suprabasal keratinocytes.  In this model, differentiation was 
induced in EZH2-depleted NHEKs and EZH2 was depleted in NHEKs 
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already differentiating under high Ca2+ conditions. Interestingly, analysis of 
depletion of EZH2 in undifferentiated keratinocytes versus differentiated 
keratinocytes showed 2.5-fold or higher expression of differentiation-
associated genes (KRT1, KRT10, FLG, LOR and TINCR) in undifferentiated 
keratinocytes compared to the differentiated keratinocytes. This result 
suggests that EZH2 depletion in undifferentiated basal keratinocytes 
stimulates and accelerates terminal differentiation, while EZH2 depletion in 
differentiating suprabasal keratinocytes neither stimulates nor accelerates 
their differentiation. These findings suggest a role for EZH2 in repressing the 
expression of both early and late epidermal differentiation genes in basal and 
suprabasal layers (spinous and granular) by modulating the timing of their 
expression to ensure an effective terminal differentiation programme.  
Taken together, these results demonstrate that PRC2-mediated regulation of 
epidermal differentiation genes is important for an effective terminal 
differentiation programme in human epidermis.  
These findings provide an important background for research to evaluate the 
possibility of modulating PRC2 activity as a therapeutic strategy for human 
skin diseases characterized by defective or abnormal epidermal 
differentiation such as atopic dermatitis and psoriasis in future. 
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5.3 PRC2 controls proliferation in primary human 
keratinocytes 
Previous studies in mice demonstrated that PRC2 core subunits control the 
proliferative potential of basal progenitors (Dauber et al., 2016; Ezhkova et 
al., 2009), hepatic progenitors (Aoki et al., 2010), subventricular zone neural 
stem cells (Hwang et al., 2014) and skeletal muscle stem cells (Juan et al., 
2011). A recent study demonstrated that EZH2 promotes the proliferation of 
human embryonic stem cells (Collinson et al., 2016). Microarray data 
obtained in this study, showed downregulation of genes involved in 
keratinocytes proliferation in EZH2 depleted NHEKs. Based on these 
findings, the effect of loss of PRC2 on keratinocyte proliferation was 
investigated by utilising siRNA and selective small molecules to inhibit EZH2 
alone or target both EZH1 and EZH2 activities in NHEKs. The analysis of the 
effect of EZH1/2 silencing revealed a significant reduction in the number of 
proliferative BrdU-positive cells and H3S28p-positive mitotic cells, as well as 
a significant increase in the number of apoptotic activated Caspase 3-
positive cells. These data are consistent with previous studies that 
demonstrated a role for PRC2 in regulating cellular proliferation (Aoki et al., 
2010; Collinson et al., 2016; Dauber et al., 2016; Ezhkova et al., 2009; 
Hwang et al., 2014).  However, Ezhkova et al. reported epidermal 
hyperproliferation in Ezh1/2 double knockout mice (Ezhkova et al., 2011), 
which contrasted with results obtained in this study in EZH1/2-depleted 
NHEKs where reduced proliferation was observed. Their investigation was in 
vivo while this study’s investigation was in vitro, this could be the reason for 
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the observed differences. Culture conditions could also be a contributing 
factor in the observed differences.  
 This study also examined if the reduced proliferation and increased 
apoptosis resulted from the activation of the INK4/ARF locus, which is up-
regulated by loss of PRC2 in mouse hair follicle stem cells (Dauber et al., 
2016; Ezhkova et al., 2011). Although, the results showed that the 
expression of p16INK4A was upregulated about 1.4-fold in EZH2-depleted 
NHEKs. Overall the changes observed in the expression of p14ARF, p16INK4A 
and p19INK4D in EZH1/2-depleted NHEKs were minimal compared to the 
control. Therefore, even though there is evidence for the regulation of the 
INK4/ARF locus in murine keratinocytes by PRC2 (Dauber et al., 2016; 
Ezhkova et al., 2009), this data does not demonstrate this in human 
keratinocytes. We speculate that an alternative pathway, which does not 
involve the INK4/ARF locus, is activated in PRC2-depleted keratinocytes that 
regulates proliferation. It will be interesting to investigate the genes and 
pathways that are regulated by PRC2 during keratinocytes proliferation in 
human epidermis in future research. 
Taken together, these results demonstrate a role for PRC2 in regulating 
human keratinocyte proliferation, though not via the INK4/ARF locus. 
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5.4 EZH2 expression is downregulated in aged NHEKs 
Senescence is associated with aging in cells. There is evidence that EZH2 
expression is downregulated in senescent and aged cell (Agherbi et al., 
2009; Bracken et al., 2007; Kamminga et al., 2006). The role of PRC2 in 
epidermal aging was examined by disrupting EZH1/2 and EZH2 activities in 
keratinocytes isolated from a young individual and keratinocytes isolated 
from older individuals. RT-qPCR analysis revealed a downregulation of 
EZH2 in keratinocytes from the older individuals compared to younger donor 
with minimal changes in EZH1 expression in both young and aged groups. 
The latter, suggests that EZH2 expression and not EZH1 is downregulated in 
aged NHEKs. This data is consistent with previous studies that have 
observed EZH2 expression downregulated in aged or senescent cells 
compared to young cells (Agherbi et al., 2009; Bracken et al., 2007; 
Kamminga et al., 2006; Kheradmand Kia et al., 2009; Tang et al., 2004). 
Increased expression of p16INK4A and p19ARF/p14ARF is associated with 
senescence and there is increasing evidence that suggests that INK4/ARF 
expression correlates with aging in various tissues in human and mouse 
(Hilpert et al., 2014; Krishnamurthy et al., 2006; Liu et al., 2009; Ressler et 
al., 2006). The expression of members of the INK4/ARF locus was examined 
in EZH1/2 and EZH2 depleted young and aged keratinocytes. RT-qPCR 
analysis revealed a marked upregulation of p16INK4A and p19INK4d with 
minimal changes in p14ARF expression in control and EZH2-depleted aged 
NHEKs compared to their young counterparts, which suggests that the 
increased expression of p16INK4A and p19INK4d in aged NHEKs correlates with 
EZH2 downregulation in these aged keratinocytes. This is consistent with 
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previous studies that demonstrated a correlation between downregulation of 
BMI-1, a PRC1 subunit that has a similar expression pattern in human 
epidermis and cancer as EZH2 (Kim et al., 2004; Lee et al., 2008; Reinisch 
et al., 2007; Vonlanthen et al., 2001), and increased p16INK4A expression in 
primary human keratinocytes from older donors (Cordisco et al., 2010) and 
aged human skin (Ressler et al., 2006). Previous studies in mice have also 
demonstrated that p19INK4d expression is upregulated in mice during aging 
(Hilpert et al., 2014). Further work needs to be done to better understand the 
involvement of EZH2 and other subunits of PRC2 in epidermal aging.   
Taken together, these results suggest that EZH2 is downregulated in aged 
primary human keratinocytes and prevents keratinocyte senescence by 
regulating the expression of p16INK4A and p19INK4d. 
 
 5.5 EZH2 is expressed in human hair follicles 
Previous data obtained in this study confirmed the expression of EZH2 in 
human epidermis. Based on this, EZH2 expression pattern was examined in 
human hair follicles (HFs) by immunohistochemical analysis. This 
investigation showed for the first time that in human anagen HF, EZH2 is 
ubiquitously expressed. However, its expression was more prominent in cells 
of the ORS, IRS and precortex than in cells of the DP and CTS.  
A previous study demonstrated that human HF bulge keratinocytes enriched 
in hair follicle stem cells (HFSCs) are CD200+/K15+/K19+ (Rittié et al., 2009), 
EZH2 expression was examined  in these HFSCs.  Immunohistochemical 
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analysis showed EZH2 is co-expressed with CD200 in the follicular bulge 
and with K15 and K19 in progenitor cells in the ORS suggesting a role for 
EZH2 in regulating the activity of HFSCs.  
Taken together, these results confirm EZH2 expression in progenitor and 
differentiating cells of human anagen HFs. Based on these findings, the role 
of EZH2 in human hair growth was investigated in this project. 
 
5.6 EZH2 is required for human hair follicle growth 
There is evidence that suggests a fundamental role for PRC2 in HF 
development and homeostasis (Dauber et al., 2016; Ezhkova et al., 2011). 
Ezhkova et al demonstrated the importance of Ezh1 and Ezh2 in mouse HF 
homeostasis (Ezhkova et al., 2011). In this study, a role for EZH2 in 
regulating human hair follicle (HF) growth was defined using human hair 
follicle organ culture (HFOC) and primary ORS keratinocytes as models. 
Through knockdown experiments using siRNA and a selective small 
molecule inhibitor in HFOC and ORS keratinocytes as well as 
immunohistochemical and RT-qPCR analyses, it was demonstrated that 
EZH2 is required for human HF growth by regulating cell proliferation and 
HFSCs activities. This study was limited to EZH2 due to a limited supply of 
human HFs. In this investigation, silencing EZH2 in human HFs resulted in 
hair growth retardation and promoted early transition from anagen to catagen 
phase, suggesting a role for EZH2 in regulating the hair cycle in humans. 
Further analysis showed that the hair growth retardation was due to reduced 
proliferation and increased apoptosis in the ORS. This is consistent with 
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earlier studies in mice where loss of Ezh2 led to defective development of 
HFs resulting from decreased proliferation and increased apoptosis in 
HFSCs (Dauber et al., 2016; Ezhkova et al., 2011). The expression of 
CD200/K15/K19 was also assessed in EZH2 depleted HFs. Notably, in EZH2 
depleted HFs K19 transcript level was significantly higher compared to the 
control. Further work needs to be done to understand why K19 is 
upregulated in EZH2-depleted HFs. 
In ORSKs, EZH2 depletion resulted in reduced proliferation, marked 
downregulation of p16INK4A and marked upregulation of p14ARF expression. 
This is consistent with earlier data from EZH2-depleted HFs that showed 
reduced proliferation and increased apoptosis. In addition, the expression of 
CD200 was significantly downregulated in EZH2 depleted ORSKs, while K15 
expression was significantly upregulated. A previous study demonstrated 
that K15+ cells were preserved while CD200+/CD34+ cells were lost in 
androgenetic alopecia (Garza et al., 2011). Further work needs to be done to 
have a clearer understanding of the role of EZH2 in PRC2-mediated 
regulation of HFSCs activities.  
Taken together, these results suggest that EZH2 promotes human HF 
growth by prolonging the anagen phase and preventing apoptosis of HFSCs 
and progenitor cells in ORS. 
In conclusion, the data obtained in this project suggests that PRC2-mediated 
gene repression is crucial for epidermal homeostasis and human hair growth 
by controlling the balance between keratinocyte proliferation, senescence, 
differentiation and apoptosis. Thus, further understanding of the mechanisms 
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controlling epidermal differentiation and epidermal stem cell activities; and 
their alterations in hair and skin disorders will assist in developing new 
therapeutic strategies targeting distinct PRC2 subunits for skin and hair 
disorders.   
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Presentations 
EZH2 is required for human hair follicle growth (Oral presentation PGR 
Mini conference, University of Bradford, 2015) 
EZH2 is required for human hair follicle growth (Poster presentation FLS 
R&D open Day, University of Bradford, 2015) 
EZH2 is required for human hair follicle growth and epidermal 
differentiation (Poster presentation World Hair Research congress Miami, 
2015) 
EZH2 is required for human hair follicle growth and epidermal 
differentiation (Oral presentation PGR Mini conference, University of 
Bradford, 2016) 
EZH2 is required for human hair follicle growth and epidermal 
differentiation (Poster presentation ESDR meeting, Munich, 2016) 
The role of Polycomb protein EZH2 in the control of terminal 
differentiation in human epidermis (Oral presentation DMS/CSS Research 
seminar, University of Bradford, 2017)  
The role of Polycomb protein EZH2 in the control of terminal 
differentiation in human epidermis (Oral presentation CSS John Wood 
Memorial Lecture, University of Bradford, 2017) 
EZH2 is required for human hair follicle growth and epidermal 
differentiation (Poster presentation BSID meeting, Manchester, 2017) 
EZH2 is required for human hair follicle growth and epidermal 
differentiation (Poster presentation FLS R&D open Day, University of 
Bradford, 2017) 
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